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ABSTRACT
An integrated lateral flow device for flow control and blood separation
Veronica Betancur Calle

Lateral flow devices (LFD) have been used and are promising in many applications,
including point-of-care diagnosis in medical, clinical, food and environmental control and
monitoring. In particular, disposable paper-based lateral flow strips utilize low-cost materials and
do not require expensive fabrication instruments. Many examples of diagnostic tests have been
developed using microfluidics paper analytical devices (μPADs), including tests for the detection
of total glucose and protein in urine (colorimetric), detection of β-galactosidase (fluorescence),
and liver enzyme tests for monitoring the health of patients been treated with multiple
medications for HIV and/or tuberculosis that can cause hepatotoxicity. However, there are
constraints on tuning the flow rate and immunoassays functionalization in paper as well as
technical challenge in integration of sensors and concentration units for low-abundant molecular
detection. In the present work, we demonstrated an integrated lateral flow device that applied the
capillary forces with functionalized polymer-based microfluidics as a strategy to realize a
portable, simplified, and self-powered LFD with minimizing the need for off-chip equipment.
The LFD combined the ability to separate plasma from human whole blood and create controlled
and steady flow using capillary forces. Lateral flow relies on surface tension and hydrophilic
natural of the flow channel, and controlled flow is also a key variable for immunoassay-based
applications for providing enough time for protein binding to antibodies. To render
polydimethylsiloxane (PDMS) surface of hydrophilicity as well as to control the flow rate,
PDMS was functionalized with different concentrations of Pluronic F127. The results show that,
in an integrated LFD, the flow rate was regulated by the combination of multiple factors,
including Pluronic F127 functionalized surface properties of microchannels, resistance of the
integrated flow resistor, the dimensions of the microstructures and the spacing between them in
the capillary pump, the contact angles, and viscosity of the fluids. The resistance of the flow
resistor had the greatest effect on the flow rate of the fluids. Plasma flow rates ranging between
0.43 and 18.60 nL/s were achieved in the flow resistor, and between 0.99 and 61.30 nL/s in the
whole device. In addition, human plasma was separated from whole blood by using a highly
asymmetric plasma separation membrane, which captured the cellular components of the blood
(red cells, white cells, and platelets), without lysis, so that only high quality plasma could flow
down into the smaller pores on the downstream side of the membrane, and into the first capillary
pump. The developed LFD can be used as a flexible and versatile platform and has the potential
for detecting circulating biomarkers from whole blood; sandwich-immunoassays can be
performed directly on the LFD by patterning receptors for analytes on the glass chip, and
detection can be performed using a variety of methods ranging from colorimetric and
fluorescence methods to more complex methods such as Surface-enhanced Raman spectroscopy
(SERS) depending on the limit of detection of the target biomarker. The bio sensing technology
being described presents an alternative for point of care testing using small samples of human
whole blood; it could benefit regions with limited access to healthcare, where delays in diagnosis
can lead to the quick deterioration of the quality of life and increase the morbidity and mortality.
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Chapter 1 Thesis Overview
1.1 The Importance of Strategy Implementation
Because financial resources are limited in developing countries, their habitants tend to
have less access to proper health services as a result of the high cost of current detection and
monitoring methods, which are often time consuming and do not provide immediate results,
delaying the process of targeting, and controlling the disease in order to prevent its worsening [1].
The delay in diagnosis, limitation in monitoring capabilities, and obstruction of the prevention of
risk factors will lead to the deterioration of the quality of life of the patients and increase the
morbidity and mortality in these areas. The outcome is a vicious cycle where poverty leads to the
decrease in health quality, and the decrease in health quality results in further socioeconomic
deterioration.
Proper and on time intervention could change the clinical outcome of the patients by
decreasing the negative impact in the quality of life by avoiding the functional deterioration left
by the aftermath and reducing the comorbidities and cost of treatment, the number of required
hospitalizations, and the mortality rate. With this in mind, there is an increasing need of methods
that allow assessing health status, disease onset and progression, and monitoring treatment
outcome for the study of these patients [2]. These methods must be user friendly, cost efficient,
reliable, portable, and generate fast results.
The second half of the 20th century has brought great advances in biochemistry and
technology, leading to greater sensitivity and more specific analysis of samples [3]. A
manifestation of this potential is in the emergence of microfluidic bioanalysis. The science of
Microfluidics concerns the controlled transport of low volumes of fluid, and it is the key for
1

miniaturization, as well as the integration of multiple functionalities, allowing for the
performance of complete laboratory protocols on a single chip [4], [5]. Performing analytical and
diagnostic tasks in microfluidic-based systems presents several advantages, including small
sample volume requirements, rapid transport times and portability, as well as allowing for
continuous flow with high precision, greatly improving the efficiency and reliability of devices
for point-of-care diagnostics [6]–[8]. Ideally, a microfluidic system should self-contained, simple
to use, flexible, robust, and its fabrication should be uncomplicated [9]. Low cost is important
because it allows delivering the technologies to a wider population. Sensitivity leads to more
reliable tests, reducing the possibilities of obtaining false positives or false negatives. As users
might come from diverse backgrounds and might not have a deep understanding of the working
mechanism, these devices must be easily operated and interpreted. These technologies could aid
reach many people in need, not only through point-of-care but also through prevention public
health brigades for marginalized and captive populations.
Unfortunately, the application of such systems in home and point-of-care situations has
been limited because they typically require external macroscopic actuators, bulky fluidic
connections, and electromechanical interfaces to initiate and control fluid flow [6], [9]–[12].
Passive flow methods are an alternative in overcoming this limitation, because they demand no
external power input, making them quite compact and thus portable; resulting in attractive
analytical tools for applications such as single use assays and simple diagnostics [6]. Capillarybased pumping takes advantage of surface tension to pull fluid through the device, so the fluid
needs only to be delivered to an inlet region (usually via pipette); the spontaneous filling of the
microfluidic network (μFN) which follows, and the subsequent continuous flow are function of
the device’s design [6], [8].
2

1.2 Research Objective
The main objective of this research is to develop a functionalized polymer based lateral
flow device (LFD) with integration of function units for studying the capillary flow and
controlling the flow rate, with the ultimate goal for the assessment of health status, disease onset
and progression, and monitoring treatment outcome. Biomarkers are measurable biological
characteristics that can serve as indicators of normal biological processes, pathogenic processes,
pharmacologic responses to therapeutic intervention, and the risk or the presence of a disease.
The objective measurement and evaluation of circulating biomarkers can therefore help in the
assessment of the biological state of a person.
The developed platform should be able to separate plasma from human whole blood,
create steady flows and control the rate of flow by using passive microfluidics, and have the
potential for detecting circulating biomarkers from the separated plasma. Specifically, the
research focuses on:
1) Development of a microfluidic platform that operates under capillary forces to initiate
and control the fluid flow. Capillary action was achieved by two means: the use of capillary
pumps, and the surface functionalization of the polydimethylsiloxane (PDMS) using Pluronic
F127. Capillary pumps (CPs) comprise microstructures of diverse shapes, with dimensions in the
micrometer range, whose position in the CPs encodes the desired capillary pressure. Because
PDMS has a hydrophobic nature, its surface was functionalized with Pluronic F127 to render it
hydrophilic.
2) Develop strategies to control the rate of flow, which would allow for providing enough
time for protein binding to antibodies and biomarker detection in the future. The binding reaction
3

between the antigen and the detection and capture antibodies takes a determined amount of time
to reach equilibrium, making the time available for binding a critical factor in the optimization of
an immunoassay. The flow rate was regulated by the combination of multiple factors, including
Pluronic F127 functionalized surface properties of microchannels, resistance of the integrated
flow resistor, the dimensions of the microstructures in the capillary pumps and the spacing
between them, contact angles, and viscosity of the fluids.
3) Integration of plasma separation membrane for performing in-situ plasma separation
from human whole blood. The highly asymmetric nature of a plasma separation membrane
allows the cellular components of the blood (red cells, white cells, and platelets) to be captured
in the larger pores without lysis, while the plasma flows down into the smaller pores on the
downstream side of the membrane.
4) The method for sensor chip integration which can provide a convenient and easy way
to work with different sensing approaches, including but not limited to colorimetry and
fluorescence. This large degree of flexibility will allow for performing different types of
immunoassays.

1.3 Significance and Novelty
Commonly used methods for quantification of protein markers in clinical setting are
immunonephelometry or enzyme-linked immunosorbent assay (ELISA). Both require a
centralized lab to separate whole blood and to perform multiple strict washing steps over several
hours. There is a strong incentive to develop a rapid point-of-care (POC) device for protein
biomarker detections with improved diagnostic modalities, enable of using minimal amounts of
blood, and capable of returning a rapid result.
4

In an attempt to address this necessity, several microfluidic devices have been fabricated
in the past with the goal of performing only a single task on a microliter volume of sample [13].
However, would it not be more effective and practical to combine the functions of different such
devices on an integrated microfluidic chip, instead of having to perform each task separately on
different devices? Although the degree of complexity increases with the integration, integrated
microfluidic devices offer several advantages, including a higher degree of accuracy,
contamination control, ease of use, rapid results, and low cost [13]. It is much easier to utilize a
single integrated device rather than using several chips, not to mention that integrated systems
can accurately control the amount of reaction agents and synchronize the reaction time in
different reactors [13].
The research work in this thesis demonstrated an integrated passive microfluidic pumping
mechanism as an alternative noninvasive monitoring tool for clinical diagnostics requiring only
30-40 µL of blood. Blood was selected as the working fluid as various disease-signaling
biomarkers can be found in it, accurately reflecting normal and disease states in humans. This
platform combines the ability to perform plasma separation from human whole blood, control the
flow rate, integrate the detection sensor, and perform biomarker sensing all in one chip, which
shortens the time of sample processing as well as allowing for rapid detection. It further
eliminates the need for blood sample pretreatment in a centralized laboratory prior to the
detection. The flow in the lateral flow device is powered by the capillary force, which was
accomplished by two means: the use of capillary pumps (CPs) [11], and the surface
functionalization of the PDMS using Pluronic F127 [12], thus eliminating the need of external
power and reducing the cost.

5

In order to extend the performance of capillary systems (CSs), we designed, fabricated
and tested a range of CSs, and compared their experimental filling behavior. The CSs were
fabricated on polydimethylsiloxane (PDMS) using soft lithography, and sealed with a blank
piece of PDMS. Because PDMS is of hydrophobic nature, it suffers serious nonspecific protein
adsorption, therefore requiring of surface modification strategies [12]. Nonionic surfactants can
adsorb strongly on hydrophobic surfaces rendering them hydrophilic and nonionic, preventing
the interaction between proteins and the surface [12], with this in mind, PDMS surface was
functionalized with Pluronic F127 to render it hydrophilic. The concentration of Pluronic was
optimized for the sake of controlling the flow rate, allowing performing reliable sandwich
immunoassays for biomarker detection. In addition, the Pluronic F127-modified PDMS has been
shown to significantly suppress the non-specific adsorption of proteins due to the improved
hydrophilicity, compared to native PDMS [14], [15].
The promise of this novel LFD lies in its potential for point of care applications, offering
an integrated and flexible platform, which can perform full laboratory procedures for the rapid
and proper diagnosis in one single chip.

1.4 The Outline of the Thesis
This thesis consists of six chapters. It is initiated with the thesis overview in Chapter
One, in which the importance of strategy implementation, research objectives, significance, and
novelty of this research were stated. Following chapter one, six chapters introduced the details of
the research work. Chapter Two is an introduction to the microfluidics field, including its
history, and the state-of-art of point of care devices for health applications. Chapter Three
described the theory behind capillary phenomena. Chapter Four introduced the design of the
6

integrated lateral flow device, demonstrated fabrication procedures and testing methodology.
Chapter Five characterized the flow rate control with the combined analysis of static/dynamic
contact angles, functionalization of PDMS, and flow resistance, as well as the blood separation
capabilities. Conclusions and future directions are summarized in Chapter Six.
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Chapter 2 Literature Review
2.1 Microfluidics for point of care immunodiagnostics
The second half of the 20th century has brought great advances in biochemistry and
technology, leading to greater sensitivity and more specific analysis of samples [3]. A
manifestation of this potential is in the emergence of microfluidic bioanalysis.
The science of Microfluidics concerns the controlled transport of low volumes of fluid, and it is
the key for miniaturization, as well as the integration of multiple functionalities, allowing for the
performance of complete laboratory protocols on a single chip [4], [5]. Microfluidics are
versatile, and serve a wide variety of purposes such as medical, agriculture, environmental (e.g.
toxicity detection), and military applications.
The most promising opportunities of microfluidics for diagnostics might reside in point
of care (POC) applications due to their portability, short sample processing time, small sample
requirements, ease of use, multiplexing capability, flexibility, and their ability to carry out
separations and detections with high resolution and sensitivity [3], [4], [16], [17]. Thanks to
these technologies, the process of targeting and controlling diseases in order to prevent their
worsening can be performed much earlier, providing patients with a much better quality of life,
and increasing the probabilities of a favorable outcome. However, the application of such
systems in home and point-of-care situations has been limited because they typically rely on
external macroscopic actuators, bulky fluidic connections, and electromechanical interfaces to
initiate and control fluid flow [4], [6], [9]–[12]. Capillary phenomena can serve as a substitute to
these external equipment in view of autonomously transporting these small volumes of fluid for
fueling miniature scaled bio/chemical processes [4].
8

We owe the existence of microfluidics to four main motivational forces: molecular
analysis, biodefence, molecular biology and microelectronics [16]. First came analysis.
Microanalytical methods such as gas-phase chromatography (GPC), high-pressure liquid
chromatography (HPLC) and capillary electrophoresis (CE) allowed for manipulating liquids at
high precision, and when combined with the power of the laser for optical detection, they made it
possible to achieve high sensitivity and high resolution with low sample volumes [3], [16]. But
these methods needed yet to become more compact and versatile [16].
Second, with the cold war came the need of counteracting the threat of chemical and
biological weapons [16]. The Defense Advanced Research Projects Agency (DARPA) supported
a series of programs for the development of field-deployable microfluidic systems which could
detect these threats [16]. This greatly stimulated for the rapid growth of academic microfluidic
technology [16].
Third, came the pushing force of molecular biology [16]. With the 1980s explosion of
genomics, as well as the advent of other areas of microanalysis related to molecular biology,
came the need analytical methods with much greater throughput, which could achieve higher
sensitivity and resolution [16].
Fourth came the contribution of microelectronics [16]. The concept of microelectronics
started around 60 years ago [4]; it inspired the ideal of miniaturization along with integration and
automatization for providing parallelism, enhanced speed, portability, and reduced consumption
of sample [4]. In microfluidics, electrons are conceptually replaced by the innumerable amount
of chemical species, and the electrical wires by miniaturized pipes [4]. Another great
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contribution from the microelectronics is the development of technologies such as
photolithography [4].
The interest of the academic research community in microfabricated microfluidic systems
started in the mid-eighties, and has been growing steadily since then [4]. Some of the first work
in microfluidics used silicon and glass, but neither of them where the most appropriate for the
analysis of biological samples [16]. Elastomers such as poly(dimethylsiloxane) allow for a much
easier fabrication process [16].
The appearance of micropumps and valves was consequence of the need of a more
precise control of liquid for advanced analysis applications [3], [18]–[20]. Pioneer work on
miniaturized total chemical analysis systems (µTAS) was done by Manz et al. (1990) and led to
the development of microfluidic high-pressure liquid chromatography systems as well as
microfluidic capillary electrophoresis (1992) [3], [21]–[23].
Following research in academia, early microfluidic life science companies such as
Caliper Life Sciences (1995), and Cepheid (1996) appeared, and Hewlett Packard started
producing

gas

chromatography,

capillary

electrophoresis,

and

high-pressure

liquid

chromatography systems for laboratories and miniaturizing analytical equipment [3]; these
companies were pioneers in the commercialization of these types of systems [3].

2.2 State-of-Art Development
The ability to understand and diagnose disease has experienced a great progress over the
past decades due to the advances in the quantification of molecular biomarkers [24]. Techniques
such as genetic sequencing, mass spectrometry, flow cytometry, and nuclear magnetic resonance
have allowed for higher sensitivity, promising improvements in early diagnosis, accurate
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monitoring of existing diseases, and understanding of the underlying causes and mechanisms of
disease. However, these techniques are highly complex, and therefore expensive, and they
require special infrastructure, and a high degree of training [24]. POC testing is one of the most
promising applications of microfluidics, since they can be performed by a clinician, or directly
by the patient, without the need of a clinical lab, and with easy handling [24], [25]. Key
requirements for a POC device include its ease of use, robustness of reagents and consumables in
storage and usage, results concordant with established laboratory methods, and being safe to use
[23]. The degree of integration of a microfluidic technology can vary from having disposable
microfluidic chips that work in conjunction with peripheral equipment (active microfluidic
systems), to having all functions needed for flow initiation and control, sample processing and
analysis, and reporting the results on a chip (passive based microfluidic systems) [25].
POC diagnostics have been available for many years, and have proven very beneficial
[24]; their success has motivated the research and development of more complex chips where
entire laboratory procedures can be performed [24]. The earliest POC tests focused on glucose
detection, and they were based on tablets containing the test reagents [26]. Technological
advances led to the development of dipstick devices, which evolved in time to self-contained
LFD (e.g., for the detection of pregnancy, cardiac disease, and HIV-1 biomarkers) [26]. After
years of evolution, current POC devices combine advances in electronics, photonics,
microelectromechanical systems (MEMS), and microfluidics to build small, low cost chips that
have a unique capability to perform full laboratory procedures in a portable device (lab-on-a-chip)
[24], [26]. Microfluidic devices for POC applications differ from conventional microfluidics in
their simplicity of use, and little or no use auxiliary external equipment [26].
In what follows some of the advances in the field of POC for health applications are discussed.
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2.2.1 Current Context of POC Assays

A number of clinical specimens (e.g., whole blood, sera, saliva, urine, and cerebrospinal
fluid) contain free-floating biomarkers that can be used for the diagnosis and monitoring of
diseases [27], [28]. Immunoassays are one of the most widely used biomarker sensing techniques
that are adapted for point-of-care microfluidic-based diagnostics [24], [29]. Current biosensor
formats aimed at disease biomarker detection use some form of immunoassay [29].
Immunoassays rely on the binding interactions between antigens and antigen specific antibodies
to detect biological markers from either pathogen or host immune responses [24], [29]. The
monomer antibodies used for immunoassay purposes possess ‘Y’ shaped structure, which
contain two antigen binding sites [29]. The recognition site of a target antigen by a specific
antibody binding site is called epitope, and even though antigens contain numerous epitopes, the
binding of an antibody to a unique epitope is highly specific, making immunoassays a highly
repeatable and highly specific reaction format [29]. Target biomarkers span the entire range of
pathogen types, from viruses (e.g., HIV, Avian Influenza, Papillomavirus, Dengue, and Hepatitis)
to bacteria (e.g., tuberculosis) and parasites (e.g., African trypanosomiasis, malaria).
Immunoassays are also commonly used for detection of noncommunicable diseases (e.g.,
cardiovascular diseases, cancer [30]–[37], diabetes) [24].
POC microfluidic platforms have been manufactured using a wide range of materials,
including glass, polydimethylsiloxane (PDMS), poly(methyl methacrylate) (PMMA), poly(cyclic
olefin), paper, and combinations of the previous [38].
2.2.1.1 Point of Care Chemiluminescent Biosensors
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In chemiluminescence, the emission of light is triggered by a chemical reaction resulting
from target binding [39]. This methodology is convenient for POC application because it doesn’t
require excitation light sources and emission filters (which is the case for fluorescence based
methods) [39]. Chemiluminescent microfluidic biosensors have been used for a variety of
applications, including the quantification of glycated hemoglobin (Figure 2-1) [40]–[43], and the
study of biomarkers for the diagnosis of Hepatocellular Carcinoma [44] and treatment
monitoring of Leukemia [45].

Figure 2-1 Microfluidic platform developed by Ko-Wei Chang et al. for the quantification of
glycated hemoglobin (Hb A1C) using an aptamer-based sandwich assay. (a) A schematic
illustration of the trilayer microfluidic chip composed of micro-components, including normallyclosed valves, a transport unit (a closed chamber), a waste chamber and five open chambers; (b)
a photograph of the microfluidic chip with dimensions of 28 mm×30 mm. Note that the red
region and blue region represent the liquid layer and the air layer, respectively; (c) an exploded
view of the microfluidic chip, which is composed of a thick-film PDMS layer for the air
channels, a thin-film PDMS layer for the liquid channels, and a glass substrate; (d) a schematic
diagram of five open chambers on the microfluidic chip for loading samples and reagents [40],
[41].
2.2.1.2 Point of Care Electrochemiluminescent (ECL) Biosensors
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In electrochemiluminiscence (ECL), luminescence occurs as result of electrochemical
reactions triggered and controlled by a set of electrodes [39]. ECL has several advantages for
POC application, including its versatility and simple optical setup (compared to
photoluminescence), its good temporal and spatial control (compared with chemiluminescence),
and its negligible background signal [39]. One of the applications of ECL microfluidic
biosensors is the study different types of cancer, including ovarian cancer [35], prostate cancer
(Figure 2-2) [36], and Colorectal Carcinoma [34].

Figure 2-2 Design of microfluidic electrochemiluminescence (ECL) array for sensitive
measurements of prostate specific antigen (PSA) and interleukin-6 (IL-6) in serum. The different
components of the microfluidic platform are identified as following: 1) syringe pump 2) injector
valve, 3) switch valve to guide the sample to the desired channel, 4) tubing for inlet, 5) outlet, 6)
poly(methylmethacrylate) (PMMA) plate, 7) Pt counter wire, 8) Ag/AgCl reference wire (wires
are on the underside of PMMA plate), 9) polydimethylsiloxane (PDMS) channels, 10) pyrolytic
graphite chip (PG) (2.5 cm × 2.5 cm) (black), surrounded by hydrophobic polymer (white) to
make microwells. Bottoms of microwells (red rectangles) contain primary antibody-decorated
SWCNT forests, 11) ECL label containing RuBPY-silica nanoparticles with cognate secondary
antibodies are injected to the capture protein analytes previously bound to cognate primary
antibodies. ECL is detected with a CCD camera [36].
2.2.1.3 Point of Care Fluorescence-based Biosensors
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Fluorescence remains one of the most widely used methods for detection thanks to the
availability of highly sensitive and selective fluorescence labeling techniques [39]. Fluorescent
dyes are composed of small molecules, proteins, or quantum dots, which emit a photon when
exited [39]. The limitation of flurescent methods lies in its need of more complex optical
detection systems compared to colorimetric methods for example [39]. Fluorescence-based
microfluidic biosensors have been used in applycations such as glycated hemoglobin
quantification (Figure 2-3) [40], point-of-care testing in case of an exposure/intoxication to
biological toxins [46], recognition of dengue virus (Figure 2-4) [46]–[48], detection of Neisseria
meningitidis bacteria [49], detection of avian influenza H5N1 virus [50], and assessment of
colorectal carcinoma biomarkers (Figure 2-5) [51].

Figure 2-3 Microfluidic platform developed by Ko-Wei Chang et al. for the quantification of Hb
A1C using a dual aptamer method in lieu of antibodies. (a) Schematic illustration of the chip and
its respective components, including six normally-closed valves, two transport unit (closed
chamber), a waste outlet, and six open chambers. (b) Photograph of the 43mm×53 mm
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microfluidic chip. The red and blue regions represent the liquid and air layers, respectively. (c)
Exposed view of the microfluidic chip, which was composed of a thick-film PDMS layer for air
control, a thin-film PDMS layer for the liquid channels, and a glass substrate. (d) Schematic
diagram of the six open chambers on the microfluidic chip for loading samples and reagents [40].

Figure 2-4 Magnetic bead-based microfluidic chip designed by Fang Lee et al. for the analysis of
dengue associated antibodies in human plasma. (a) A photograph of the microfluidic chip,
comprising one and two-way micropumps, a four-membrane type micromixer, and an on-chip
microcoil array. The dimensions of this chip are measured to be 53mm × 37mm. (b-1) A
schematic diagram of the four-membrane-type micromixer; (b-2)–(b-5) show the motion of the
fluids in the micromixer [52].
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Figure 2-5 Microfluidic protein chip for an ultrasensitive and multiplexed assay of cancer
biomarkers in human serum, in the format of both sandwich and reverse phase immunoassay. (a)
Schematic illustration of the microchannel network. (1) First, a PDMS piece was placed in a
silyated slide; (2) The solutions were flowed through the channels, and the first layer of protein
was immobilized; (3) The first PDMS piece was removed; (4) The other PDMS piece was placed
on the substrate with channels perpendicular to the first PDMS piece; (5) Other solutions were
flowed; (6) A two dimensional array was formed above the chip. (b) Schematic illustration of a
sandwich immunoassay and reverse phase immunoassay based on CdTe/CdS quantum dots-IgG
fluorescent probes and microfluidic protein chip [51].
2.2.1.4 Point of Care Electrochemical Biosensors

Electrochemical methods take advantage of the interaction of chemical species with
electrodes or probes to obtain electrical signals, allowing for the quantification of target analytes
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present in the sample [39]. Electrochemical events can occur in two different orders, the first
possibility is that the chemical reaction is triggered by passing an electrical current through the
electrode system, the second is that the electrode responses are triggered by specific chemical
reactions such as oxidation and reduction [39]. Applications of electrochemical microfluidic
sensors include the diagnosis of tumor biomarkers (2-6) [33], and coagulation status monitoring
[53].

Figure 2-6 The schematic representation of microfluidic paper-based three-dimensional
electrochemical device, developed by Wang et al. for the simultaneous diagnosis of two tumor
markers: cancer antigen 125 and carcinoembryonic antigen. (A): Wax-patterned paper sheet; (B):
the 3D--µPED, (a) paper working zones; (b) paper auxiliary zone. (C): Screen-printed electrodes,
(c) carbon working electrodes; (d) Ag/AgCl reference electrode; (e) carbon counter electrode; (f)
silver conductive channel and pad; (g) transparent polyethylene terephthalate substrate. (D):
After stacking, the paper working zones and the paper auxiliary zone will be aligned to the
screen-printed working electrodes, counter and reference electrode, respectively [33].
2.2.1.5 Point of Care Surface Acoustic Wave (SAW) Biosensors

Surface acoustic wave biosensors rely on the modulation of surface acoustic waves to
sense a physical phenomenon. In general, this devices generate and detect acoustic waves using
interdigital transducers on the surface of a piezoelectric crystal [54]. SAW microfluidic
immunosensors have been used in the detection of carcinoembryonic antigen (CEA) [55], [56]
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Figure 2-7 PDMS microfluidic chip coupled with Love Wave sensor. (b) Picture of the PDMS
microfluidic chip. (c) Schematic of the circuit for Love Wave sensor measurement. (c) Printed
circuit board [55].
2.2.1.6 Point of Care Colorimetric Biosensors

Colorimetric

biosensors

take

advantage

of

the

color

change

caused

by

chemical/biochemical reactions between the target analytes and the colorimetric probes [39],
[57]. The advantage of this methodology for POC application lies in the ability of observing
results with the naked eye, thus eliminating the need for bulky external detection systems [39],
[58]. One of the most well-known colorimetric biosensors is the hCG pregnancy test strip [59],
[60], however, these colorimetric biosensors have also been used for other applications such as
multiplexing detection of Hepatitis B biomarkers (Figure 2-8) [61], human immunodeficiency
virus (HIV) biomarkers (Figure 2-9) [62], the detection of papillomavirus [63] and anemia [64].
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Figure 2-8 Modified PDMS microfluidic ELISA device for the multiplexing detection of IL-5,
HBsAg, and IgG in human serum. The microfluidic device encompassed several microchannels
to guide the flow to a detection well, and then drain out to the waste outlet manifold by overflow,
in such a way that backflow of the reacted fluid is eliminated, in order to avoid contamination. (a)
Top view, (b) Section view of microfluidic ELISA device [61].

Figure 2-9 Schematic diagram and pictures of microfluidic device, and data on fluid handling of
a POC ELISA-like assay for the simultaneous diagnosis of HIV and syphilis. (a) Picture of
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microfluidic chip. Each chip can accommodate seven samples (one per channel), with molded
holes for coupling of reagent-loaded tubes. (b) Scanning electron microscope image of a crosssection of microchannels, made of injection-molded plastic. Scale bar, 500 µm. (c) Transmitted
light micrograph of channel meanders. Scale bar, 1 mm. (d) Schematic diagram of passive
delivery of multiple reagents, which requires no moving parts on-chip. A preloaded sequence of
reagents passes over a series of four detection zones, each characterized by dense meanders
coated with capture proteins, before exiting the chip to a disposable syringe used to generate a
vacuum for fluid actuation. (e) Illustration of biochemical reactions in detection zones at
different immunoassay steps. The reduction of silver ions on gold nanoparticle–conjugated
antibodies yields signals that can be read with low-cost optics (for quantification) or examined
by eye. (f) Absorbance traces of a complete HIV-syphilis duplex test as reagent plugs pass
through detection zones. High optical density (OD) is observed when air spacers pass through
the detection zones, owing to increased refraction of light compared to in the liquid filled
channels. The train of reagents mimics the pipetting of reagents in and out of multiwall plates.
This sample was evaluated (correctly against a reference standard) as HIV negative and syphilis
positive. Ag, antigen [62].
2.2.1.7 Point of Care Localized Surface Plasmon Resonance Biosensors

Localized surface plasmon resonance (LSPR) optical phenomena is generated by the
interaction of light resulting with conductive nanoparticles with a smaller size than the incident
wavelength [65]. The electric field of incident light is used to excite electrons of a conduction
band, resulting in coherent localized plasmon oscillations with a resonant frequency strongly
dependant on the composition, size, geometry, dielectric environment and separation distance of
the gold nanoparticles [65]. Localized Surface Plasmon Resonance Biosensors have been used in the
diagnosis of prostate cancer [37], and microalbuminuria (Figure 2-10) [66].
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Figure 2-10 Nanobiosensor based on localized surface plasmon resonance (LSPR) for the
detection of microalbuminuria. The principle (left) and technologies developed (right) for
forming the LSPR POC system [37].
Table 2-1 further summarized state of the art of POC microfluidic platforms for
biomarker detection [38].
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Table 2-1 Summary of biomarker detection using microfluidic platforms [38].
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2.3 Limitations
While the development of microfluidic technology for diagnostics and disease monitoring
has evolved rapidly over the past years, to this date, these technologies still face several
challenges for becoming truly viable for POCT [27]. For one, many of the technologies available
still require some degree of training for handling the device, sample treatment, and even
expensive external equipment for flow initiation and control as well as detection, and do not
meet the portability requirement, which are all great limitations especially for low-resource
settings. Detection methods like colorimetry are simple and low cost, however, they might not be
as sensitive and somewhat compromise quantitation [39]. Other significant challenges remain in
working with human sample matrices [27]. Also, each different human sample type and each
disease biomarker require special assay development [27]; it is very complex to recreate a
versatile platform which can be used with a broad spectrum of input species or clinical patient
samples [27].

2.4 Chapter Summary
In summary, a number of microfluidic platforms have been developed for the rapid
detection of disease biomarkers, using materials ranging from paper to polymers and hybrid
materials [39]. Some of these platforms are designed to perform individual steps, and can only be
used to test human serum and not whole blood, but the critical challenge is to integrate these
steps into a sensitive and selective integrated device that meets all the POC requirements
including portability, low cost, and ease of handling [27]. To date only a small number of
devices that offer total analysis on chip, including reagent storage, and sample collection and
preparation, or the ability to test crude real-world samples (e.g. blood, urine, and saliva) [39],
24

[67]–[69]. The microfluidics community is in need of integrated POC solutions that can be used
not only in research laboratory settings, but can also be delivered directly to patients. These
integrated POC solutions would help bridge the healthcare gap between developed and
developing countries [70].
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Chapter 3 Capillary Systems Theory
3.1 Capillary Phenomena
Capillary phenomena designate the forces produced by interfacial tensions (N/m) at the
interface of at least two immiscible phases, and the spontaneous transformation and dissipation
of the interfacial energy into motion of a liquid [4], [71], [72]. These effects become
predominant at small scales, where the forces exerted by the molecules at the interface surpass
the forces arising from the molecules in the bulk [4]. Even though significant only at micrometer
scales, capillary phenomena forms part of our everyday life [4].
Capillarity has been studied since da Vinci’s time [71]. Leonardo da Vinci’s observation
of the capillary rise of liquid in tubes was the first recorded observation of capillary action [71].
In his book of 1759, Giovani Batista Clemente Nelli describes that a former student of Galileo,
Niccolo Aggiunti (1600-1635), had also studied capillary action in mosquitoes, butterflies, and
bees feeding [73]. Other studies soon followed [74]–[79]. Mathematicians Honoré Fabri and
Jacob Bernoulli thought that liquids rose in capillaries because air couldn't enter capillaries as
easily as liquids, so the air pressure was lower inside capillaries [80], [81]. Other scholars like
Isaac Vossius, Giovanni Alfonso Borelli, Louis Carré, Francis Hauksbee, and Josia Weitbrecht
thought that the particles of liquid were attracted to each other and to the walls of the capillary
[82]–[89]. It took until 1805, for two investigators, Thomas Young and Pierre-Simon Laplace, to
successfully quantify capillary action [90], [91]; they derived the Young-Laplace Equation of
capillary action. Carl Friedrich Gauss then determined the boundary conditions governing
capillary action in 1830 [92]. The effect of the meniscus on a liquid's vapor pressure, and the
interaction between two immiscible liquids were determined by William Thomson and Franz
Ernst Neumann respectively [93], [94].
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3.1.1 Wetting and Interfacial Free Energy

When a small drop of liquid is put onto a flat solid surface, two distinct outcomes,
representative of two different equilibrium regimes can occur [95], [96]. The first is partial
wetting, where the liquid drop has a finite contact angle α with the surface; the second is total
wetting, where the liquid spreads out as a thin molecular film [4]. The magnitudes of the free
energy per unit area (J/m2) of each interface can be related via the contact angle α of the liquid to
the surface, using Young’s equation [4].
𝛾𝐿𝑉 ∗ cos(𝛼) = 𝛾𝑆𝑉− 𝛾𝑆𝐿 ( 1 )
Where γLV,

SV, SL

are free energy per unit area of the liquid-gas, solid-gas, and solid-liquid

interfaces respectively (Figure 3-1) [4].

Figure 3-1 (a) Surface tension forces at the three-phase line on a non-deformable solid surface
[97].
If the boundary between wettable and non-wettable is 90º [4]; a surface is wettable when
the magnitude of the contact angle is lower than 90º, and non-wettable if the contact angle is
greater than 90º [4]. For the case of water, the wettability can be defined as hydrophilicity (α‹90º)
and hydrophobicity (α›90º) [4].
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3.1.2 Dynamics of capillary flow in a microchannel

In autonomous capillary systems (CSs) liquids are displaced by means of capillarity [98].
Their proper functioning requires displacing accurate volumes of liquids with precise flow rates
[98]. The flow velocity of a liquid in a conduit can be derived from solving the Navier−Stokes
equations [4].
The flow rate of a liquid is a function of the viscosity of the fluid, the capillary pressure,
and the total flow resistance of the flow path (governed by the device’s geometry), and can be
calculated by integrating the flow velocity (Equation 2) [4], [99].
𝑄=

𝛥𝑃
8𝜂

∗

𝐴∗𝑅𝐻
𝐿

(2)

where η is the viscosity of the fluid, RF is the total resistance of the flow path, and ΔP is
the differential pressure between inlet and outlet, L is the length, A the area, and 𝑅𝐻 is the
hydraulic radius of the microchannel (Equation 5). During filling by capillary action ΔP can be
replaced with the pressure generated at the liquid meniscus, or capillary pressure (Pc) [4], [98].
The geometric and constant parameters can be regrouped for convenience into a unique
parameter that we call the total flow-rate resistance, resulting in a simplified equation for flow
rate (Equation 3) [4].
1

𝛥𝑃

1

𝑃

𝑄 = 𝜂 ∗ 𝑅 = 𝜂 ∗ 𝑅𝑐 ( 3 )
𝐹

𝐹

The total flow rate resistance (RF) of the flow path for a rectangular microchannel is not
trivial to calculate, but it can be approximated by a linear term as long as 𝑎 < 𝑏 (Equation 4) [4],
[100].
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1

5𝑎

𝑅𝐹 = [12 (1 + 6𝑏) ∗

2
𝑎𝑏𝑅𝐻
]−1
𝐿

(4)

𝑎𝑏

𝑅𝐻 = 𝑎+𝑏 ( 5 )

Where a and b are the depth and width of microchannel respectively [4], [98]. When
filling the microchannel due to capillary action, the parameter L corresponds to the filled length
of the channel, consequently, it increases with the advancement of the filling front of the liquid
in the channel [4]. For a system with varying cross-sections connected in series, the total RF of
the system can be calculated as the sum of the different components with constant cross-sections
[4].
3.1.2.1 Capillary Pressure

The capillary pressure (Pc) is the difference in pressure across the interface between two
immiscible fluids, in this case plasma and air, and can be described by the Young-Laplace
equation [4]. For a microchannel with a rectangular cross section, the curvature along the depth
and width axes contributes to the meniscus pressure [4]. Pc

can then be calculated using

Equation 6 [4], [101].
𝑃𝑐 = −𝛾(

𝑐𝑜𝑠𝛼𝑏 +𝑐𝑜𝑠𝛼𝑡
𝑎

+

𝑐𝑜𝑠𝛼𝑙 +𝑐𝑜𝑠𝛼𝑟
𝑏

(6)

where γ is the surface tension of liquid, and αb,t,l,r are the contact angles of the liquid on
the bottom, top, left, and right wall of the microchannel respectively. The dynamic contact angles
of the liquid with the walls of the microchannel depend on the speed of flow, as well as the
receding or advancing state of the interface [4].
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When using the static contact angles of the liquid with the substrate to calculate Pc, the
four contact angles are assumed to be equal in magnitude, simplifying the calculation (Equations
7-9).
𝑃𝑐 = 𝛾(𝑅

1
𝐻𝑒𝑖𝑔ℎ𝑡

+𝑅

1
𝑊𝑖𝑑𝑡ℎ

) (7)

𝑎

𝑅𝐻𝑒𝑖𝑔ℎ𝑡 = 2∗𝑐𝑜𝑠𝛼 ( 8 )
𝑏

𝑅𝑊𝑖𝑑𝑡ℎ = 2∗𝑐𝑜𝑠𝛼 ( 9 )
Where RHeight and RWidth are the minor and mayor radii of curvature respectively, and α is
the static contact angle.
3.1.2.2 Viscosity

Viscosity can be thought of as a measure of fluid friction: the greater the viscosity, the
greater its resistance to flow [102]. More formally, it is a measure of its resistance to deformation
by shear or tensile stress arising from the collision between neighboring particles in a fluid,
moving at different velocities [50]–[52]. For Newtonian fluids (e.g blood plasma), its magnitude
can be calculated as the ratio of the shearing stress to the velocity gradient in a fluid [4], [102]–
[104]. For the case of Non-Newtonian fluids (e.g blood), the relationship between shear stress
and the velocity gradient is no longer linear, and therefore requires more complex calculations
[102].
Viscosity is mainly a function of the material, but it also varies with temperature:
increased temperature will result in less viscous fluids [102], [103]; this occurs because as
temperature increases, the average speed of the molecules in the liquid increases as well,
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resulting in a reduction of intermolecular forces [103]. However, in this thesis the temperature is
assumed to be constant during the operation of microfluidic devices [102].
The behavior of whole blood is that of a non-Newtonian fluid, meaning that its viscosity
is dependent on shear rate (shear thinning or thickening) [105]. Shear rate is a function of the
blood flow velocity, and as a result, when blood moves quickly (e.g. peak-systole), the shear is
high and the blood is thinner, and when it moves slowly (e.g. end-diastole), the shear is lower,
and blood becomes thicker due to red blood cell aggregation [105]. In conclusion, the viscosity
of blood dynamically changes during each cardiac cycle [105].
On the other hand, serum and plasma are Newtonian fluids, so their viscosity does not
change with the flow velocity, and therefore it is easier to measure [105], [106]. The viscosity of
plasma is determined by its water-content and macromolecular components [106]. Since plasma
is a highly concentrated protein solution, the proteins will have an effect in its viscosity based on
their molecular weight and structure [106]; higher molecular weights will result in higher
aggregating capacity, and together with their sensitivity to higher temperatures or pH, will result
in higher plasma viscosity values [106]. Normal plasma viscosity ranges between 1.10 and 1.30
mPa∙s at 37°C, however, alterations might occur due to pathologies that cause inflammations (e.g.
rheumatoid arthritis), tissue injuries, unstable angina pectoris and stroke, and sometimes their
higher values are associated with the progression of the disease and higher rate of major adverse
clinical events [106].
For the purpose of our study, the viscosity of both Phosphate-buffered saline (PBS) and
plasma was measured with the aid of a viscometer at room temperature, and the values were
found to be 1.04 and 1.66 mPa∙s respectively. The measured value for the viscosity of PBS is
comparable to reported by Fluxion Biosciences [107]. However, the measured value for the
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viscosity of human blood plasma is slightly higher than normal levels, which can be consequence
of pathologies, inflammations, amongst others [106].
3.1.2.3 Hagen-Poiseuille’s Law

In fluid dynamics, the Bernouilli’s equation is an application of the law of conservation
of mechanical energy to a moving fluid [108]. This is the simplest model for the flow of a fluid
through a channel [108]; however, it assumes that the fluid is incompressible and that there is no
friction effect on it as it moves in the channel, which is not the case in microfluidics [108].
The Hagen-Poiseuille equation describes a physical law that relates the pressure drop in
an incompressible, Newtonian fluid flowing in the laminar regime through a channel with
constant cross-section (no acceleration) [102]. All which are characteristic of microfluidic
systems [102].
Ideally, Hagen-Poiseuille’s law applies for perfectly straight and infinitely long channels
[102]; however, it can be used as a reasonable estimate for channels with finite length (L) as long
as L is the prevalent dimension of the geometry [102].
3.1.2.4 Analogy Between Fluidic and Electric Circuit

The behavior of fluids in channel networks has a great resemblance with currents in
electric circuits [109]. In electronics, the resistance (RE) of linear resistors can be described by
Equation 10:
𝑅𝐸 =

𝝆𝑬 ∗𝑳𝑬
𝑨

( 10 )

Where ρE is the resistivity of the conductor in ohm, LE is the length of the conductor in
meters, and A the cross-sectional area in meters squared [102].
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The voltage (V) across the conducting material can be calculated using Ohm’s law, which
says that V is equal to the current (I) flowing through the conductor times R E. Ohm’s law finds
its fluidic counterpart in Hagen-Poiseuille’s law, which is described by Equation 11 as follows:
𝛥𝑝 = 𝑅ℎ ∗ 𝑄 ( 11 )

Where Δp is the pressure drop across the microchannel in Pa, Q the volumetric flow rate
in m3/s, and Rh the hydraulic resistance in Pa*s/ m3 [102]. The hydraulic resistance of a
rectangular microchannel can be approximated by:
𝑅ℎ =

𝛱𝐺 ∗𝜂∗𝐿𝐶
𝑏∗𝑎3

( 12 )

Where LC is the length of the channel in meter, a and b are the depth and width of
microchannel respectively in meter, and ΠG is a dimensionless parameter defined as:
𝛱𝐺 = 12 ∗ (1 −

192∗𝑎
𝜋 5 ∗𝑏

𝜋∗𝑏

∗ tanh ( 2∗𝑎 ))−1 ( 13 )

In a similar way to electric resistors, for N fluidic resistors (microfluidic channels)
arranged in series, an equivalent single fluidic resistor has a hydraulic resistance equal to the sum
of the N hydraulic resistances, because each resistor is carrying the same volumetric flow from
one end to the other [102]. For parallel connected fluidic resistors the equivalent single fluidic
resistor has a hydraulic resistance equal to the reciprocal of the sum of reciprocals of each
hydraulic resistance [102].
German physicist Gustav Kirchhoff greatly contributed to the understanding of electric
circuits by stating two fundamental laws [110]. The first law is commonly called Kirchhoff’s
current law (KCL), and it says that at any point of the electric circuit, the sum of the currents
flowing towards a node is equivalent to the sum of currents flowing out of the node [110]. This
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law has a counterpart in fluidic circuits: the conservation of mass, which states that the sum of
the flows into a node should be equal to the sum of the flows leaving the node [102].
In a similar way, the second law (Kirchhoff’s voltage law) also has a counterpart in
fluidic networks, which implies that the sum of each pressure drop along the closed path is zero
[102].
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Chapter 4 Capillary Driven Microfluidic Platform
4.1 Background
Microfluidic systems have the potential of significantly changing how modern biology is
done, due to their unique ability of integrating entire laboratory procedures onto a single chip
[111]. These systems comprise a series of different basic components in order to perform the
required functionality and the basic microfluidic operations [112], [113]. These basic
components include: a method of introducing reagents and samples, methods for fluid transport,
and a method for combination and mixing [113]. Some systems further extend their capabilities
by integrating other components such as detection and in-chip sample processing [113].
Miniaturization leads onto the area of small Reynolds numbers, where fluid dynamics are
very different from the macro scale, and different forces and effects dominate [111], [114]; the
effects that become dominant in the micro scale fluidics include laminar flow, diffusion, fluidic
resistance, surface area to volume ratio, and surface tension [111], [114]. Microfluidic systems
should be designed in such a way that they take advantage of forces and effects that work on the
micro scale [111].
Here, we describe a strategy to initiate fluid flow by taking advantage of surface tension,
control the rate of flow by modifying both the hydraulic resistance encoded by the flow resistor
and modifying the PDMS surface properties by functionalizing it using Pluronic F127, separate
plasma from human whole blood, and potentially perform biomarker detection.
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4.2 Design of an Integrated Lateral Flow Device
A lateral flow device (LFD) operated under the capillary force was designed for the detection
of circulating biomarkers. The integrated LFD is composed of two layers, a bottom fluid layer
and a top interfacing layer (Figure 4-1). The fluidic layer consists of a membrane-based plasmaseparation unit, a capillary pump (CP) for plasma extraction/delivery unit, a detection chamber, a
flow resistor, and a second capillary pump for assisting fluid flow and waste collection. The
interfacing layer consists of the reservoir for whole blood loading, an embedded prefunctionalized glass substrate, and waste collection. The plasma separation membrane will be
trimmed and put in a close contact with the microstructures in the 1st capillary pump.

A
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B

Figure 4-1 A) Schematic diagram of lateral flow device (LFD) for detection of single biomarker
in whole blood sample. The first capillary pump (CP1) is partially covered by a GR plasma
separation membrane, and it is designed for plasma extraction, while the second capillary pump
(CP2) is designed to assist the fluid flow. Surface-immunoassays can be performed directly on
the sealed chip by patterning capture antibodies on the gold chip placed on top of the detection
chamber area. B) Schematic of assembled LFD. The black arrows indicate the flow direction.
Ideally, the capillary pumps should generate smooth flow of the fluid in the capillary system
(CS), filling the CS completely without entrapping air. Therefore the CP must have low flow
resistance and high capillary pressure [98]. Advanced capillary pumping structures can further
enhance the pumping capabilities of the CS [98]. The pioneer work for capillary pumping
systems had been demontrated by Delamarche et al., in which the characteristic dimensions of
the structures, width and spacing, affect the progression rates of the liquid in the vertical and
horizontal directions [9], [98]. In our LFD, the 1st CP for plasma extraction was designed with
symmetric elongated structures (260 μm wide, 1041 μm long, and with a 260 μm spacing
between structures) to control the filling front of the fluid, and 2nd CP for assisting fluid flow and
waste collection was designed with symmetric elongated microstructures as well (160 μm wide,
640 μm long, and with a 160 μm spacing between structures). In capillary pumps with symmetric
structures, the resulting filling front is parallel to the microstructures [98]. For an enclosed
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capillary pump, such as ours, there is a risk of entrapping air; symmetric structures reduce this
risk since the filling fronts of liquid converge from the edges of the CP towards its center [98].
Accurate control of the flow is a key in providing enough time for protein binding to
antibodies and biomarker detection; fluidic resistances of microchannels allow modulating the
flow rate passively [115]. In our case, the resistance of fluid resistor was modified by means of
varying the length of the flow resistor. Lengths studied ranged from 0.324 cm to 37 cm, while
the width and depth of the channel were kept constant at 200 µm and approximately 20 µm
respectively.

4.3 Chapter Summary
The novelty of this work lies in the high degree of flexibility and the integration of all
functions required to perform a sandwich immunoassay through POC techniques. The LFD can
separate human plasma from a droplet of whole blood, initiate and control the flow using a
combination of resistance and surface modification techniques, and has the potential for
detection of different biomarkers using a wide range of methodologies (e.g., colorimetric
methods, fluorescence), all in a single chip. The LFD is portable, easy to handle, and low cost
since it does not rely on expensive external equipment.
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Chapter 5 Fabrication and Testing
5.1 Fabrication
5.1.1 Background

Materials dictate the properties of the microfluidic flow path in a large extent [3]; they
influence flow rate, capillary pressure, wetting, optical properties, adhesion of biomolecules,
cost, and the fabrication methods required [3]. Glass and silicon were the first generation
microfluidics materials thanks to their capillary electrophoresis and solvent-involved
applications; the downside to these materials is that they are expensive for microfabrication, and
for the case of silicon, its opacity to visible and ultraviolet light, which present a limitation for
conventional optical methods of detection [16]. Since then, a wide of materials and different
fabrication techniques have been explored (Figure 5-1) [3], [116]. Elastomeric Polymer materials
are widely used in microfluidics due to their ease of fabrication and surface modification, optical
transparency to visible and UV light, biocompatibility, flexibility, low cost, and it can be used to
pattern both planar and non-planar surfaces [147], [149]; they also allow for complicated and
parallel fluid manipulation [117]. Plastics are also rapid and inexpensive to microfabricate [117];
their broad variety makes them more flexible for different applications [117]. Hydrogels are
highly permeable, so they allow for diffusion of molecules without bulk fluid flows [117]; they
are non-toxic to cells, cost effective and commercially available [118]. Paper also presents a lowcost, biocompatible, easy to use alternative, and it can be disposed after use [117]. Fluidic
sample manipulation and biomarker detection can be performed in paper substrates thanks to the
hydrophilicity of its fibers [119]; in addition, paper can be modified chemically to incorporate a
wide variety of functional groups that can be covalently bound to proteins, DNA, or small
molecules, and due to its white color it is a good medium for colorimetric tests, which makes
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them a good option for point-of-care applications [120]. One of the drawbacks of paper-based
microfluidic devices is the complex patterning of the channels on the chip [118]. These materials
can also be combined into hybrid chips in order to exploit their complementing advantages [117],
[121].

Figure 5-1 Microfluidics are fabricated in a variety of materials, including glass, silicon, paper,
elastomers like PDMS, hydrogels, thermoplastics, and thermosets. Fabrication processes differ in
degrees of complexity, and therefore in cost. The selection of the material to be used will depend
on several factors, including the application, the target audience, and the fabrication capabilities
[117].
5.1.1.1 Capillary Systems Using Different Materials

Silicon-based Microfluidics
One of the advantages of using silicon in microfluidics it’s the capability to fabricate
virtually any geometrical microstructure with high precision [122]. Silicon has high chemical
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resistance, mechanical strength, temperature stability, and it benefits from well-established
MEMS fabricating and integration processes [123]. However, as previously mentioned, this
material is not optically transparent in the UV/ visible region, limiting detection capabilities, and
it is also very costly to fabricate, which greatly limits its usage in low-income settings [122]. In
addition, Silicon has a hydrophobic nature, so it needs to undergo treatments in order to become
hydrophilic (e.g. chemical treatment to make silicon surface OH terminated) [124]. A widely
accepted procedure for rendering silicon wafers hydrophilic is the RCA cleaning [124], [125];
RCA consist of an aqueous solution of ammonia and hydrogen peroxide [124].
Glass-based Microfluidics
Glass has a good chemical resistance and it is very good for detection purposes thanks to
its optical transparency, and its surface is hydrophilic in nature [122]. However, conventional
glass capillary devices still have several limitations, including the complexity and cost of the
fabrication methods [122], [126]. Recently, there has been some research on simplifying
fabrication processes to overcome such limitations [126]–[128]. An example is the work of
Benson et al., who developed a flow focusing glass capillary device based on commercially
available chromatography components for easy assembly, disassembly, and cleaning [126].
Paper-based Microfluidics
Paper is an attractive substrate for microfluidic applications due to its availability and low
cost, biocompatibility, and its ability to transport liquids using capillary forces, without the need
of external equipment [129]. The first report on paper-based microfluidics might be the work of
Müller et al. in 1949 [129]; their work consisted of creating confined channels by patterning
filter paper using paraffin barriers, for the study on the preferential elution of a mixture of
pigments [129], [130]. Paper microfluidics field has rapidly grown since then [129].
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There are two types of “Lab-on-a-paper” devices for affordable disease diagnosis: The
first consists of on demand devices, which are blank platforms that can be used for a variety of
tests [129]. Upon the selection of the test to be performed, samples and reagents can be and
added prior to the execution of the test [129]. The second consists of ready-to-use devices, which
are test-specific, and already integrate the required reagents [129]. Most of the published works
to date focus on the second type, since they are easier to handle by the patient [129]. Table 5-1
lists the different analytes studied to date using “Lab-on-a-paper”technologies [129].
Table 5-1 Summary of the reported detection methods, example analytes and applications for
both paper-based microfluidic devices and paper-based microarray plates [129].

Although paper-based microfluidic devices have many advantages, they too have several
limitations, which are related to the material properties of paper, fabrication techniques, and
detection methodologies [129]. One of the limitations is sample retention and sample
evaporation during fluid transport, which result in only 50% or less of the total volume reaching
the detection zones [129]. Another limitation is the strength of the hydrophobic barriers, as some
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times it is not enough to withstand samples with low surface tension [129]. In addition,
traditional detection methods have a high limit of the detection when integrated in paper
substrates, making it problematic when analyzing samples of lower concentrations [129].
Polymer–based Microfluidics
Polymers are widely used in microfluidics, and they possess several advantages including
biocompatibility, low cost (in comparison to glass and silicon), and ease of fabrication using a
diversity of techniques, and bonding [131]. Their chemical resistance, optical transparency, low
autofluorescence, and absence of UV absorption capabilities can be compared to those of glass
[122]. The variety of surface chemistries also allows the usage of different immobilization
techniques for the antibodies and/or antigens [122]. However, polymers often require surface
functionalization in order to acquire certain properties such as hydrophilicity [132]. A key
elastomer in microfluidics is PDMS, thanks to its relatively low cost and ease of fabrication, the
capability of modifying its surface to render it hydrophilic, the ability to reversibly and
irreversibly bond to other materials including glass, plastic, and other PDMS pieces, its
elasticity, amongst others [133]. In addition, micro-scale features can be reproduced with high
precision, it is optically transparent down to 280 nm so it can be used with a large number of
detection methodologies, it is nontoxic and can be cured at low temperatures, and can be bonded
reversibly or irreversibly [131]. However, PDMS also has some drawback such as its absorption
of small molecules, the leaching

of uncrosslinked oligomers, and the vapor permeability

(evaporation effects can occur) [133]–[136]. Several surface modification methods have been
used to overcome the hydrophobic nature limitation of PDMS [137]; such methods can be
classified in three categories: gas-phase processing methods (e.g. plasma oxidation, ultraviolet
(UV) irradiation, chemical vapor deposition (CVD) and sputter coating of metal compounds),
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wet chemical methods (e.g. layer-by-layer (LBL) deposition, sol–-gel coatings, silanization,
dynamic modification with surfactants and protein adsorption), and a combination of the
previous [137].
In addition to PDMS, other polymeric materials have been used, including polycarbonate,
polymethymethacrylate (PMMA), polystyrene, polypropylene, and PVC [122], [137].
Hybrids
There is no optimal material for all microfluidic applications. The selection depends on
the specific application. In this work, we decided to take advantage of the capabilities of
different materials in order to make an integrated hybrid capillary microfluidic platform
combining PDMS polymer, paper, and glass. This allowed us to perform plasma separation from
whole blood, antibody immobilization for detection in the near future, and flow initiation and
control using capillary forces.

5.1.2 Method

Polydimethylsiloxane (PDMS) is a clear, colorless silicon-based organic polymer, and it is
the most popular material for microfluidic research and prototyping due to its ease of fabrication,
biocompatibility, nontoxicity, optical transparency, and gas permeability. However, because of
its hydrophobic nature and strong adsorption of biological molecules such as proteins, PDMS is
not suitable to be directly used to fabrication devices used in analytical, biological, and clinical
applications. In this work, PDMS was functionalized with Pluronic F127 to modify its
hydrophobic surface for the LFD fabrication and operation. The molecules of pluronic have a
triblock structure, consisting of one hydrophobic polypropylene oxide (PPO) group accompanied
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by two hydrophilic polyethylene oxide (PEO) units [138]. The general structure is PEOn-PPOmPEOn, where m and n vary based on the type of pluronic (for pluronic F127, m=100, n=65,
molecular weight=12600) [138], [139]. The PPO chain attaches to the hydrophobic polymer
(PDMS), while the PEO chains self-assemble into a cilia-like surface on the PDMS, effectively
repelling proteins [138], [140]. Pluronic copolymers are an important type of surfactants due to
their low toxicity and immunogenic response; they are approved for medical applications by the
US Food and Drug administration [138], [140].
The microchannels networks were fabricated using standard photolithography and soft
lithography techniques [141]. The process consisted of utilizing a high-resolution photomask to
expose and polymerize a polymer-based photoresist spun cast onto a silicon wafer [6]. Following
development, the resulting three-dimensional (3D) structure was used as a template for
replication in Pluronic F127 (Sigma-Aldrich Co.) functionalized PDMS (Sylgard 184). The 5
mm by 10 mm glass chips where cut using a diamond tip, and the interfacing layer was then
fabricated by placing the chips on a 10.16 cm by 10.16 cm petri dish, and casting the Pluronic
functionalized PDMS on the dish, followed by degassing, and curing 1 hour at 60 ºC. The result
consisted of a clean, flat Pluronic functionalized PDMS surface, with the glass chip embedded in
it, which was then bonded to the PDMS replica (flow layer) to generate a sealed microfluidic
network.
SU-8 2025 negative photoresist (Microchem) was used for fabricating the fluidic layer mold.
SU-8 2025 was spin coated on a silicon wafer to a thickness of 20 μm, exposed to UV radiation,
and rinsed in SU-8 developing solution to create the microchannel templates. Channel height was
then measured using a Stylus Profilometer.
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200 mg of Pluronic F127 were dissolved in 1 mL of alcohol. Samples with 20 µL and 40 µL
of this complex were mixed thoroughly with the freshly made uncured 10 g PDMS, resulting the
final Pluronic concentration as 2 µL/g and 4 µL/g, respectively. The PDMS/Pluronic mixed
solution was then cast over the SU-8 master mold creating an inverse replica of the design, and
cured for one hour at 60 °C. Once cured, the PDMS/Pluronic layer was removed from the master
mold. Inlets and outlets for the fluids were cut out from the interfacing layer using a sharpened
puncher (Figure 5-2).

Figure 5-2 Photograph of the fluidic microchannels
In aqueous environments, the Pluronic migrates towards the surface due to the high gradient
between the water and the PDMS substrate, resulting in a reduction of nonspecific adsorption
and an enhancement of wetting [138], [139]; for this reason, both layers were immersed in 500
mL de-ionized water for 24 h at room temperature. After the 24 h immersion, the surfaces of
both the flow and the interfacing Pluronic functionalized PDMS layers were dried with nitrogen
gas and then exposed to oxygen plasma treatment for 30 seconds. The flow layer was
immediately placed in conformal contact with the interfacing layer, irreversibly bonding them
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together, ensuring that the glass chip on the interfacing layer was placed directly on top of the
detection chamber on the flow layer, and then stabilized in an oven at 60 °C for half an hour.

5.2 Flow Rate Control
5.2.1 Background

Flow control is a key in the proper functioning of microfluidics devices, and it can be
achieved by using a combination of valves, pumps, and resistances [3]. The overall flow rate of
the fluid is encoded by the pumping mechanism, which can be either active (e.g. reciprocating
movement membrane valve, capillary electrophoresis using electro-osmotic flow, centrifugal
force in Lab on a CD devices, electro wetting) or passive (e.g. porous capillary membrane,
capillary pump, vacuum driven suction) depending on the application requirements [3], [142].
5.2.1.1 Active Pumping

These type of microfluidic systems require external macroscopic actuators such as
syringe pumps, peristaltic pumps, air pressure pumps, multiport valves, sensors, and even
computers for flow rate control [168], [178]–[180]. Flow can be driven by mechanical
displacement, electrical fields, magnetic fields or centripetal force [3].
Active pumping setups provide a higher degree of interactive control, and the allow for
controlling liquids in a broad range of flow rates, pressures, viscosities, molecular weights and
compositions, but at the expense of complexity, lack of portability, scaling, and cost [3], [4]; for
this reason their main application is in research settings [3].
Syringe pumps are frequently used in microfluidics due to their ease of use [3]. The
working mechanism consists of a stepper motor which causes the syringe’s plunger to move at a
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constant speed, encoding the desired flow rate, while small tubing connect the syringe to the
microfluidic chip [3]. Microfabricated mechanical displacement pumps actuate a membrane or
diaphragm in a reciprocating mode [3], [143], [144].
Electro-osmotic pumping is based on a chemical equilibrium at the interface between a
liquid and a solid, resulting in a charged surface and counter ions in the liquid [3]. When
applying an electrical current, the counter ions will move with the electrical current, creating a
pressure gradient and therefore flow of the liquid [3]. However, electro-osmotic pumping has
some weaknesses, including the sensitivity to impurities that adsorb on the wall of the channel
and to changes in composition of the buffer, ohmic generation of heat in the fluid, and the need
for very high voltages and therefore macroscopic power supplies [4].
Another approach is the lab on a CD, where the liquid is loaded into a reservoir near to
the disk’s center, and when the rotated at varying speeds, the liquid is pumped through the
microfluidic channels thanks to centrifugal force [3].
Electrowetting devices apply pulses of electrical potentials between ground and actuation
electrodes creating electrostatic and dielectrophoresis forces that temporarily change the wetting
properties, rendering the surface hydrophilic, which allows for fluid flow [3].
Several alternate active pumping schemes has been reported in scientific literature [4].
5.2.1.2 Passive Pumping

Flow rates in passive pumping are a function of the design. Passive microfluidics uses
chemical gradients on surfaces, osmotic pressure, permeation in PDMS, or capillary forces to
drive the fluid through the microfluidic channels [3]. These systems have spontaneous filling and
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present an attractive alternative due to their portability, zero power consumption, low volume
requirement, low cost, and ease of handling [3]. However, these devices offer less flexibility of
modification by the user.
In capillary systems (CS), liquids are displaced by means of capillarity. Their proper
functioning requires displacing accurate volumes of liquids with precise flow rates [98]. The
capillary pressure is a function of the depth and width of the microchannels, the surface tension
(γ) and contact angles with the bottom, top, left and right side walls [3]. The capillary resistance
is a function of the geometry of the channel, and together with capillary pressure and viscosity of
the fluid (η), it can aid in calculating the flow rate [3]. Capillary pumps (CPs) encompass micro
pillars of diverse shapes and dimensions, whose position in the capillary pump (CP) encodes the
desired capillary pressure [98], and together with their shape, will determine the filling front of
the liquid in the CP as well as the flow rate [98]. The high differential pressures created by the
CPs allow for supplying near-constant continuous flow over the course of several minutes [8].
Berthier et al. investigated a microfluidic passive pumping method relying on surface tension, in
which a small inlet drop was placed on the entrance of a microfluidic channel, creating higher
pressure than that of a larger output drop at the channel exit, resulting in the flow of the fluid
[145]. Other methods require an additional user induced pressure (manual pressure), such is the
case of the control scheme developed by Vestad et al. by which capillary networks flow could be
dynamically controlled through simple external pressure and membrane deflection [6].
Sometimes controlling more than one working fluid is necessary, for example for multiplexing
biomarker detection or parallelization of miniaturized bio/chemical processes [9]; Junker et al.
developed a CS that could autonomously transport aliquots of different liquids in sequence [9].
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Capillary driven microfluidics systems are low cost, easy to handle, and portable, so they
are a good alternative for POC applications, however, they do present some challenges such as
evaporation of liquid in loading pads, blocked channel due to debris or defects, and higher
resistance with lower dimensions, which can be addressed with a proper design and
manufacturing process [3].
5.2.2 Contact Angle Measurement

To understand the effect of resistance variation, and Pluronic concentration in the PDMS,
and verify the hydrophilicity of the surface, the static and dynamic contact angles of several
samples were measured. Concentrations of 2 µL/g and 4 µL/g were taken into account
(concentrations lower than 2 µL/g were also studied but the contact angle variation was very
small, while concentrations higher than 4 µL/g turned out too cloudy, which could conflict with
optical detection methods).

Because contact angles on the channel wall surfaces may be

significantly different from smooth and flat surfaces [146], both the static and in-situ dynamic
contact angles were measured and compared to study the wettability of PDMS surfaces
with/without Pluronic functionalization. Static contact angle on the flat surface was measured
using a handheld digital microscope (Celestron, LLC), by placing the microscope in horizontal
position (parallel to the substrate), such that an image of the droplet outline and its reflection on
the substrate could be taken; static contact angles were analyzed using Image J software (NIH).
For the dynamic contact angle measurement, a drop of liquid (40µL) was placed in the inlet port
of the LFD, and the air-liquid interface was recorded by performing a time-lapse imaging using a
Nikon Eclipse Ti microscope, using objective lenses with a magnification from 4× to 20×. NISElements Viewer (Nikon Instruments Inc.) was then used for analysis. Experiments were
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performed for both PBS and Human Blood plasma, on both water treated and Pluronic
functionalized PDMS without water treatment.
In addition, the dynamic contact angles were measured for all five flow resistors, in order
to evaluate the relationship between the resistance and contact angle. For statistical analysis, data
was

presented

as

the

mean

±

standard

derivation

(SD)

and

each

individual

measurement/experiment was performed at least three times (n > 3).
Note that in this work we describe two types of fluidic resistances. The first, total flowrate resistance is function of the geometry of the microchannels alone (Equation 4); while the
second, hydraulic resistance, accounts for not only the geometric parameters but also the
viscosity of the fluid flowing through the channels (Equation 10). Since the total flow-rate is
only function of geometry and is independent of viscosity, its magnitude is equivalent for both
PBS and Plasma for each individual flow resistor (Table 5-2). On the other hand, the magnitude
of the Hydraulic resistance is always higher for plasma since its viscosity is greater than that of
PBS (Table 5-2).
Table 5-2 Total flow-rate resistance vs. Hydraulic resistance PBS
Channel geometry
Length of
Depth of the
microchannel microchannel
(cm)
(μm)
0.324
28.4
3
10
20
37

27.3
25.1
25
22

Total flow-rate resistance (m-3)
Width of the PBS
Plasma
microchannel
(μm)
200
9.90E+15
9.90E+15
(no flow
(no flow
resistor)
resistor)
200
1.02E+17
1.02E+17
200
4.35E+17
4.35E+17
200
8.80 E+17
8.80 E+17
200
2.35 E+18
2.35 E+18

Hydraulic resistance (kg*m-4*s-1)
PBS
Plasma
9.689E+12
(no flow
resistor)
1.01E+14
4.28E+14
8.67E+14
2.33E+15

1.54659E+13
(no flow
resistor)
1.61E+14
6.84E+14
1.38E+15
3.72E+15
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5.2.3 Results
5.2.3.1 Dynamic vs. Static Contact Angle Measurement

Due to the hydrophobic nature of the PDMS, surface modification via functionalization
with Pluronic F127 was necessary. The effects of the surface modification and the variation of
the flow resistor’s resistance on the characteristics of the capillary flow were studied in five
different microfluidic devices. Table 5-3 presents a summary of the parameters measured in this
work.
Table 5-3 Summary of measured parameters
Contact
angles

Static

PBS




Plasma



Dynamic PBS




Plasma

Control
Pluronic Functionalized
PDMS [2 µL/g]
Pluronic Functionalized
PDMS [4 µL/g]




Water treated
Non Water
treated

Pluronic Functionalized
PDMS [2 µL/g]
Pluronic Functionalized
PDMS [4 µL/g]



Water treated:
partial
immersion
Water treated:
full immersion
Non Water
treated




Flow rate

PBS
Plasma

Five different
resistances




Pluronic Functionalized
PDMS [2 µL/g]
Pluronic Functionalized
PDMS [4 µL/g]




Water treated:
partial
immersion
Non Water
treated

Static contact angles measured from smooth flat surfaces can greatly differ from in situ
dynamic contact angles, and they do not account for the resistance encoded by the constricted
microchannel and the structures in the capillary pumps (influenced by their shape, size, and
spacing between structures). Static contact angles were measured by dispensing a droplet of
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Plasma or PBS on the surface of the Pluronic functionalized PDMS (without water exposure).
The angles were continuously monitored for a period of 20 minutes (Figure 5-3) [147]. As a
point of comparison, dynamic contact angles were measured using Nikon Eclipse Ti microscope.
For the flow resistor, dynamic contact angle measurements were always taken at the entrance
channels for consistency. The inverted microscopy technique allowed for measuring only the top
and bottom dynamic contact angles (αb and αt), however, side angles can be calculated using
Equation 6. Static contact angle measurements where used in the flow equations in order to
compare the theoretical and the experimental flow rate.

Figure 5-3 Representative images showing the change of the static contact angles of a 10 μL
droplet of plasma Pluronic functionalized PDMS [4 µL/g]. A) Initial contact angle just after
dispensing the droplet. B) 5 min after dispensing the droplet. C) 10 min after dispensing the
droplet. D) 15 min after dispensing the droplet. E) 20 min after dispensing the droplet.
Table 5-4 Static contact angle without water treatment
Plasma
Control
Static contact angle (mean ±SD)

Pluronic/PDMS Pluronic/PDMS
[2 µL/g]
[4 µL/g]
79.82°±3.91° 68.42°±5.22°
69.85°±1.30°
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Static contact angles were measured for a continuous period of 20 minutes as to provide
enough time for the droplet contact angle to stabilize [147]. The angles where originally
hydrophobic, and the change from hydrophobic to hydrophilic occurred after 5 minutes [147].
Table 5-4 shows the magnitude of the stabilized static contact angle after 20 minutes. For the
pluronic functionalized samples, the concentration of pluronic had a very small impact on the
static contact angle.
On the other hand, the pluronic concentration had a greater effect on the dynamic contact
angle (Figures 5-4B and 5-4C). Dynamic contact angles proved more hydrophilic with increase
in the concentration, however, the flow resistance proved the mayor influence in both the
magnitude of the contact angles, and more importantly, the flow rate. The contact angle was
measured for sets of identical microchannels, with the only difference being the concentration of
the Pluronic in the PDMS. The contact angle proved to be reduced as concentration increased
(Table 5-5). It is known that the pillar aspect ratio and their positioning in the capillary pumps, as
well as and the physical properties of the fluid (e.g. surface tension, viscosity), have a great
impact on the capillary phenomena in the microchannel [148], [149]; with this in mind contact
angles were also measured in both the first and second capillary pumps. In a similar way to the
flow resistor’s contact angles, the capillary pump’s contact angles had a tendency to decrease
with higher concentrations of pluronic (Tables 5-6 and 5-7). The effect of the resistance,
determined by the microstructures in the capillary pump, on the magnitude of the contact angle
can be observed in Figure 5-5. The contact angle proved more hydrophilic for the CP2 than those
of the CP1.
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Figure 5-4 A) Schematic of Dynamic contact angle in Flow Resistors. The interface has concave
contact lines for the side walls and nearly flat (90°) contact lines for the top and bottom walls;
the contact lines with the top and bottom walls can also have a convex shape when the contact
angle is greater than 90°. The light area represents the plasma phase, which moves from left to
right. B) Highly hydrophilic microchannel (Pluronic/PDMS [4 µL/g]). C) Less hydrophilic
microchannel (Pluronic/PDMS [2 µL/g]). The black arrows indicated the flow direction in the
microchannel.
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Figure 5-5 Representative results showing the dynamic contact angles in the capillary pumps. A)
CP1, Plasma, Pluronic functionalized PDMS (Pluronic/PDMS [4 µL/g]). B) CP2, plasma,
Pluronic functionalized PDMS (Pluronic/PDMS [4 µL/g]). C) CP1, PBS, Pluronic functionalized
PDMS (Pluronic/PDMS [2 µL/g]). D) CP2, Plasma, Pluronic functionalized PDMS
(Pluronic/PDMS [2 µL/g]). The black arrows indicated the flow direction in the capillary pumps.

Tables 5-5, 5-6, and 5-7 show that αb and αt measurements often tend to be close to 90°
or larger; this occurs because the dynamic contact angle tends to increase rapidly in response to
increased wetting speed [146], [150]. If the dynamic angles of the left and right side walls (αl and
αr) were assumed to be equal to αb and αt, the capillary pressure would be zero or negative,
resulting in a stationary interface or the interface moving in the opposite direction, which would
contradict the observed experimental results [146]. The fact that the meniscus moved in the
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positive implies that αl and αr are smaller than 90° [146]. Figure 5-4A shows the threedimensional schematic of the interface in the functionalized channels.
Table 5-5 Dynamic contact angle in flow resistor (Top/Bottom)
Flow resistance
(m-3)

PBS
Pluronic/
PDMS
[2 µL/g]
mean±SD

Pluronic/
PDMS
[4 µL/g]
mean±SD

Plasma
Pluronic/
PDMS
[2 µL/g]
mean±SD

9.90E+15
(no flow resistor)
1.02E+17
4.35E+17
8.80 E+17
2.35 E+18

91.80°±1.83°

101.75°±8.03° 105.60°±3.07°

102.47°±2.54°

99.43°±3.50°
91.87°±1.96°
101.00°±1.31°
107.00°±8.07°

94.30°±5.21°
88.60°±11.78°
63.25°±4.90°
96.00°±8.48°

73.58°±15.67°
58.90°±4.96°
95.45°±2.85°
91.30°±1.67°

106.80°±4.66°
104.00°±1.00°
108.26°±3.31°
94.00°±3.67°

Pluronic/
PDMS
[4 µL/g]
mean±SD

Table 5-6 Dynamic contact angle in cp1 (Top/Bottom)
Flow
resistance
(m-3)

7.73E+15
8.69E+15
1.11E+16
1.13E+16
1.64E+16

PBS
Pluronic/
PDMS
[2 µL/g]
mean±SD
Top/Bottom
Contact Angle
98.17°±2.40°
104.50°±2.52°
95.75°±2.99°
103.50°±2.08°
104.06°±1.93°

Pluronic/
PDMS
[4 µL/g]
mean±SD

Plasma
Pluronic/
PDMS
[2 µL/g]
mean±SD

Pluronic/
PDMS
[4 µL/g]
mean±SD

Top/Bottom
Contact Angle
107.89°±3.14°
94.75°±2.75°
90.42°±1.36°
87.62°±2.43°
80.28°±2.87°

Top/Bottom
Contact Angle
107.50°±6.40°
117.20°±7.08°
97.50°±1.97
109.33°±6.03°
96.62°±2.87°

Top/Bottom
Contact Angle
96.75°±5.06°
91.50°±0.58°
100.00°±2.21°
101.17°±5.60°
108.00°

The left and right contact angles can be estimated by calculating the experimental flow
rate for each component and using the equations in Section 3.1.2 to find the αl and αr that would
encode that flow rate.
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Table 5-7 Dynamic contact angle in cp2 (Top/Bottom)
Flow
resistance
(m-3)

3.17E+16
3.56E+16
4.55E+16
4.60E+16
6.69E+16

PBS
Pluronic/
PDMS
[2 µL/g]
mean±SD
Top/Bottom
Contact Angle
93.67°±1.53°
90.00°±0.82°
28.40°±6.27°
78.17°±6.53°
91.92°±2.06°

Pluronic/
PDMS
[4 µL/g]
mean±SD

Plasma
Pluronic/
PDMS
[2 µL/g]
mean±SD

Pluronic/
PDMS
[4 µL/g]
mean±SD

Top/Bottom
Contact Angle
93.06°±1.86°
84.67°±3.05°
44.62°±5.56°
42.86°±6.82°
32.00°±6.24°

Top/Bottom
Contact Angle
95.12°±4.87°
81.00°±1.73°
71.50°±2.26°
81.00°±1.82°
102.80°±1.92°

Top/Bottom
Contact Angle
103.00°±4.24°
57.25°±2.50°
53.37°±3.68°
70.25°±1.26°
44.31°±6.29°

Contact angle in each function unit [2 µL/g]
140

Dynamic contact angle (deg)

120

100
Flow resistor-PBS
Flow resistor-Plasma
CP1-PBS
CP1-Plasma
CP2-PBS
CP2-Plasma

80

60

40

20

0
5.10 E+16

1.49 E+17

4.94 E+17

9.40 E+17

2.44 E+18

Total resistance of entire device (m-3)

Figure 5-6 Dynamic contact angle in each functional unit of the device using a Pluronic/PDMS
concentration of [2 µL/g]
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Contact angle in each function unit [4 µL/g]
120

Dynamic contact angle (deg)

100

80

Flow resistor-PBS
Flow resistor-Plasma
CP1-PBS
CP1-Plasma
CP2-PBS
CP2-Plasma

60

40

20

0
5.10 E+16

1.49 E+17

4.94 E+17

9.40 E+17

2.44 E+18

Total resistance of entire device (m-3)

Figure 5-7 Dynamic contact angle in each functional unit of the device using a Pluronic/PDMS
concentration of [4 µL/g]
Figures 5-6 and 5-7 show the variation of the dynamic contact angle for each functional
unit of the LFD, considering the change in resistance and in the concentration of pluronic. The
dynamic contact angle is often lower for higher concentration of pluronic. In addition, the angle
usually lowest in magnitude for the secondary capillary pump, as the wetting velocity is
decreased as consequence of the additive resistance from all previous functional units (as these
units are connected in series).
5.2.3.2 Flow rate

Flow rate was regulated by varying the dimensions of the microstructures in the capillary
pump and the spacing between them, as well as the dimensions of the flow resistor, resulting in
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their resistance changes; this allowed for providing more time for the binding of proteins to
antibodies, and detection. The capillary pumps determine the filling front of the system, and their
resistance is highest when they are almost full; however, the resistance of capillary pumps is few
orders of magnitude smaller than the total flow resistance of the capillary system. In addition,
the concentration of Pluronic also had to be optimized. In order to be able to predict the effect of
the combination of the resistance and the Pluronic concentration on the flow speed, in-situ
dynamic contact angle measurements were performed for different solutions, which were then
compared with the time-lapse results. The concentration of Pluronic F127 and geometric flow
resistances had great impact in the flow speed of the sample. Higher concentrations of Pluronic
reduced the contact angle, therefore increasing the hydrophilicity of the device and allowing for
higher flow rates. Longer flow resistors encoded a higher fluidic resistance therefore reducing
the magnitude of the flow rate. Flow rate was measured by measuring the time required for the
fluid to flow through each component of the CS. Table 5-8 shows the relationship between the
flow rate of the flow resistor, the geometry based fluidic resistance, and the concentration of
Pluronic. The highest flow rate (18.4 nL/s) achieved was for a device with no flow resistor
(straight channel), and a pluronic concentration of 4μL/g; the lowest flow rate was achieved with
a 37 cm long flow resistor (0.43 nL/s), and a concentration of 2μL/g. Flow rate is higher for PBS
than Plasma due to its viscosity and surface tension.
Time lapses using the Ti microscope were used to analyze how the flow rate decays over
the length of the channel. Table 5-9 shows the flow rate of Plasma at the entrance of the flow
resistor, and at the middle of the same for two devices. Even though the flow rate decays over the
length of the resistor, the flow rate of the device with lower fluidic resistance is higher at all
times. The decay in speed occurs not only due to viscous dissipation forces, but predominately
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due to the increase in length of the filled length in the channel and the friction due to the bulk
viscosity [4].
Table 5-8 Flow rate of entire flow resistor

Resistance of the
Flow resistor (m-3)

No flow resistor
1.02 E+17
4.35 E+17
8.80 E+17
2.35 E+18

Flow rate of the entire flow resistor
mean±SD (nL/s)
Pluronic/
PDMS
[4 µL/g]

Pluronic/
PDMS
[2 µL/g]
PBS
9.20±0
12.15±0.64
4.08±0.60
2.37±0.20
1.20±0.07

Plasma
18.4±0
9.94±0.43
3.17±0.46
1.24±0.61
0.43±0.10

PBS
18.40±0
2.06±1.46
3.12±0.90
1.70±0.72
0.98±0.06

Plasma
18.40±0
12.60±0
2.37±0.18
1.65±0.11
0.52±0.01

Flow rate of entire flow resistor (Plasma)
20
Pluronic functionalized PDMS [2 µL/g]
Pluronic functionalized PDMS [4 µL/g]

Flow rate (nL/s)

15

10

5

0
9.90 E+15

1.02 E+17

4.35 E+17

8.80 E+17

2.35 E+18

Total resistance of flow resistor (m-3)

Figure 5-8 Relationship between the geometric resistance variation and the flow rate of plasma.
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Note from Figure 5-8 the general tendency of flow rate to increase as the concentration of
pluronic increases, as well as when the geometric resistance is reduced (which occurs at shorter
lengths).
Zimmerman et al. had previously reported studies on flow rate control taking advantage
of the effect of the secondary capillary pump alone [149]. Their studies were only able to tune
the flow in a very short range of velocities (0.2-3.7 nL/s) by modifying the dimensions and
positioning of the micropillars in the capillary pumps [149]. Even though our work used a set of
dimensions for each capillary pump, we took advantage of other factors, including the flow
resistor resistance and the concentration of pluronic, and were able to increase this range from
0.43 to 18.4 nL/s. As previously mentioned, time is a key variable for performing immunoassays
using microfluidic technology, so widening the range of flow rates provides much flexibility, and
the perfect setting for tuning the time for immunoassays in the future.
Table 5-9 Decay of flow rate across the flow resistor (Pluronic/PDMS [4 µL/g])
Fluid

Flow resistance
(m-3)

Plasma

4.35E+17
8.80 E+17

Flow rate
entrance
mean±SD
(nL/s)
2.99±0.14
1.93±0.32

Flow rate
middle
mean±SD
(nL/s)
1.31±0.07
0.71±0.06

Tables 5-10 and 5-11 show the relationship between the flow rate of the Capillary pumps,
the geometry based fluidic resistance, and the concentration of Pluronic. Flow rate was highly
consistent for CP1 due to the fact that a large portion consists of an open window where the
plasma separation membrane is placed (Figure 5-9). The flow rate in CP2 had a general tendency
to increase as resistance decreased and as concentration of pluronic increased (Figure 5-10).
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Table 5-10 Flow rate in first capillary pump

Resistance of the
Capillary pump
(m-3)
7.73E+15
8.69E+15
1.11E+16
1.13E+16
1.64E+16

Flow rate of the first capillary pump
mean±SD (nL/s)
Pluronic/
PDMS
[2 µL/g]

Pluronic/
PDMS
[4 µL/g]

PBS
818.40±0
786.70±0
723.30±0
720.40
633.97±0

PBS
818.40±0
786.70±0
723.30±0
720.40
633.97±0

Plasma
818.40±0
786.70±0
723.30±0
720.40±0
633.97±0

Plasma
818.40
786.70±0
723.30
720.40±0
633.97±0

Flow rate of first capillary pump

Flow rate (nL/s)

1000

800

Pluronic/
PDMS
[2 µL/g]-PBS

600

Pluronic/
PDMS
[2 µL/g]-Plasma

400

Pluronic/
PDMS
[4 µL/g]-PBS

200

Pluronic/
PDMS
[4 µL/g]-Plasma

0
7.73 E+15

8.69 E+15

1.11 E +16

1.13 E+16

1.64 E+16

Total resistance of first capillary pump (m-3)
Figure 5-9 Flow rate in first capillary pump

63

Table 5-11 Flow rate in second capillary pump

Resistance of the
Capillary pump
(m-3)
3.17E+16
3.56E+16
4.55E+16
4.60E+16
6.69E+16

Flow rate of the second capillary pump
mean±SD (nL/s)
Pluronic/
Pluronic/
PDMS
PDMS
[2 µL/g]
[4 µL/g]
PBS
30.62
15.19±1.83
4.22±0.65
1.63±0.29
0.94±0.09

Plasma
38.55±7.85
8.88±1.80
2.08±0.52
0.90±0
0.32

PBS
45.49±15.44
15.36±0.32
3.03±0.69
1.88±0.56
1.00±0.14

Plasma
34.61±1.58
12.11±3.72
1.43±0.46
1.34±0.06
0.61±0.11

Flow rate of second capillary pump
70

60

Pluronic/
PDMS
[2 µL/g]-PBS

Flow rate (nL/s)

50
Pluronic/
PDMS
[2 µL/g]-Plasma

40

Pluronic/
PDMS
[4 µL/g]-PBS

30

Pluronic/
PDMS
[4 µL/g]-Plasma

20

10

0
3.17 E+16

3.56 E+16

4.55 E+16

4.6 E+16

6.69 E+16

Total resistance of second capillary pump (m-3)
Figure 5-10 Flow rate of secondary capillary pump
5.2.3.3 Water Treatment
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As previously mentioned, the properties of the Pluronic in the PDMS where further
enhanced by DI water treating the LFD in order to trigger the gradient-induced migration of the
pluronic embedded in the PDMS. This treatment would further enhance the hydrophilic
properties of the microfluidic channels, and it would also make the surface more stable and less
prompt to nonspecific adsorption. Two methods where compared. The first consisted of fully
immersing the LFD in DI water for 24 hours, and the second consisted in placing the patterned
surface of the fluidic layer as well as the surface of the interfacing layer in contact with the DI
water for the same 24 hours (Figure 5-11). Contact angles were measured using both methods,
and proved to be much lower for the devices partially immersed in water compared to those fully
immersed (Tables 5-16 and 5-17); flow rate was in consequence higher for the partially
immersed devices.

Figure 5-11 Schematic of process of surface modification. A) Before water treatment. B) Water
treatment by full immersion. C) Water treatment by partial immersion.
Flow rate was also measured and compared for devices with and without the water
treatment, for both the entire device and the flow resistor portion (Tables 5-12 to 5-14). Even
though contact angles proved to be more hydrophilic (Figure 5-12), and flow rate was higher at
the entrance of the channels, it was observed during experimentation that the effects of
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evaporation where more evident in water treated devices, which resulted in the full length flow
rate been lower compared to that of the non-treated ones.

Figure 5-12 Contact angle of water treated (partially immersed) LFD at the flow resistor. The
concentration of pluronic was 4 µL/g. The black arrow indicates the direction of the flow.
Table 5-12 Flow rate of entire device without water treatment

Resistance of
Resistance of
the
Entire
the Flow
Device (m-3)
resistor (m-3)
5.10 E+16
1.49 E+17
4.94 E+17
9.40 E+17
2.44 E+18

No flow
resistor
1.02 E+17
4.35 E+17
8.80 E+17
2.35 E+18

Flow rate of the entire device
mean±SD (nL/s)
Pluronic/
PDMS
[2 µL/g]

Pluronic/
PDMS
[4 µL/g]

PBS

Plasma

PBS

Plasma

101.11±5.21

60.70±0.98

127.77±9.77

61.30±4.62

29.32±1.18
8.83±1.50
3.61±0.32
1.87±0.16

18.88±2.27
4.96±1.17
2.02±0.05
2.32±0.22

32.18±1.10
6.35±1.87
3.59±1.44
1.71±0.06

27.76±8.16
5.23±1.66
2.86±0.19
0.99±0.09
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Table 5-13 Flow rate of entire device with water treatment

Resistance of
the Entire
Device (m-3)
5.10 E+16
1.49 E+17
4.94 E+17
9.40 E+17
2.44 E+18

Resistance of
the Flow
resistor (m-3)
No flow
resistor
1.02 E+17
4.35 E+17
8.80 E+17
2.35 E+18

Flow rate of the entire device
mean±SD (nL/s)
Pluronic/
Pluronic/
PDMS
PDMS
[2 µL/g]
[4 µL/g]
Plasma
56.72±6.35

Plasma
31.79±5.69

23.49±1.04
3.84±1.27
1.96±0.12
1.48±0.09

28.57±4.10
3.13±0.24
1.85±0.84
1.62±0.38

Figure 5-13 shows the effect of the resistance, the concentration of pluronic and the water
treatment on the flow rate of the entire device. The resistance has the most impact on the flow
rate.

Flow rate (nL/s)

A

60

y = 1E+17x-0.923
R² = 0.929

50
40
30
20
10
0
0

2E+18
Total resistance of entire device (m-3)
[2 µL/g]

Power ([2 µL/g])
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y = 2E+20x-1.1
R² = 0.9919

B 70
60
Flow rate (nL/s)

50
40
30
20
10
0
0

2E+18
Total resistance of entire device (m-3)
Pluronic functionalized PDMS [4 µL/g]
Power ( Pluronic functionalized PDMS [4 µL/g])

Flow rate (nL/s)

C 60

y = 9E+18x-1.03
R² = 0.9593

50
40
30
20
10
0
0

2E+18
Total resistance of entire device (m^-3)
Pluronic functionalized PDMS [2 µL/g]
Power (Pluronic functionalized PDMS [2 µL/g])
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D 40

y = 8E+16x-0.916
R² = 0.8898

35

Flow rate (nL/s)

30
25
20
15
10
5
0
0

2E+18
Total resistance of entire device (m^-3)
Pluronic functionalized PDMS [4 µL/g]
Power ( Pluronic functionalized PDMS [4 µL/g])

Figure 5-13 Flow rate of the entire device. A) Pluronic Functionalized PDMS [2 µL/g] without
water treartment. B) Pluronic Functionalized PDMS [4 µL/g] without water treartment. C)
Pluronic Functionalized PDMS [2 µL/g] with water treartment. D) Pluronic Functionalized
PDMS [4 µL/g] with water treartment.

Table 5-14 Flow rate of entire flow resistor with water treatment

Resistance of
the Flow
resistor (m-3)
No flow
resistor
1.02 E+17
4.35 E+17
8.80 E+17
2.35 E+18

Flow rate of the entire flow resistor
mean±SD (nL/s)
Pluronic/
Pluronic/
PDMS
PDMS
[2 µL/g]
[4 µL/g]
Plasma
2.96±0.22

Plasma
3.27±1.37

2.82±0.72
3.55±1.00
1.04±0.22
0.70±0.08

3.61±0.28
1.99±0.45
1.72±0.04
0.86±0.25

Both static and dynamic contact angles where measured to observe the effect of the water
treatment (Table 5-15 to 5-17).
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Table 5-15 Static contact angle after water treatment
Plasma

Static contact angle (mean ±SD)

Pluronic/PDMS [2 µL/g]

Pluronic/PDMS [4 µL/g]

65.60°±2.67°

69.74°±1.65°

Static contact angle of plasma on Pluronic functionalized PDMS

Static Contact angle (deg)

80

60

40

20

0
Pluronic/PDMS [2 µL/g]-non treated
Pluronic/PDMS [4 µL/g]-non treated
Pluronic/PDMS [2 µL/g]-water treated
Pluronic/PDMS [4 µL/g]-water treated

Figure 5-14 Comparison of static contact angle with and without water treatment
The water treated static contact angle only presented a very slight decrease in comparison
of its non-treated counterpart (Figure 5-14). However, the dynamic contact angles presented a
more evident change; contact angles are generally lower for the partially immersed devices since
this treatment triggers a gradient, leading the pluronic molecules to merge to the surface of the
microchannels (Figure 5-15).
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Table 5-16 Dynamic contact angle of flow resistor after water treatment (full immersion)

Resistance of
the Flow
resistor (m-3)
No flow
resistor
1.02 E+17
4.35 E+17
8.80 E+17
2.35 E+18

Contact angle of flow resistor after
water treatment
mean±SD (nL/s)
Pluronic/
Pluronic/
PDMS
PDMS
[2 µL/g]
[4 µL/g]
Plasma

Plasma

95.75°±3.20°

84.50°±4.95°

97.00°±3.56°
89.37°±0.92°
76.83°±8.75°
99.25°±0.96°

36.92°±7.97°
67.75°±4.35°
56.5°±2.12°
61.75°±7.80°

Table 5-17 Dynamic contact of flow resistor after water treatment (patterned face in contact with
water)

Resistance of
the Flow
resistor (m-3)
No flow
resistor
1.02 E+17
4.35 E+17
8.80 E+17
2.35 E+18

Contact angle of flow resistor after
water treatment
mean±SD (nL/s)
Pluronic/
Pluronic/
PDMS
PDMS
[2 µL/g]
[4 µL/g]
Plasma

Plasma

76.5°±9.25°

95.83°±4.95°

57.25°±4.86°
54.89°±5.92°
45.46°±3.60°
38.00°±6.68°

68.21°±3.87°
67.00°±9.53°
45.46°±3.60°
44.00°±9.11°

71

Dynamic contact angle in flow resistor
120

Dynamic contact angle (deg)

100

80

60

40

20

0
9.9 E+15

1.02 E+17

4.35 E+17

8.80 E+17

2.35 E+18

Flow resistance (m-3)
Pluronic/PDMS
Pluronic/PDMS
Pluronic/PDMS
Pluronic/PDMS

[2 µL/g]-full immersion
[4 µL/g]-full immersion
[2 µL/g]-partial immersion
[4 µL/g]-partial immersion

Figure 5-15 Comparison of dynamic contact angle of water treated devices based on the
immersion mode.
Finally, the experimental results were validated using the equations in chapter 3. Both the
static and dynamic contact angles were evaluated separately to determine which one would be a
better predictor of the flow rate. Results showed that the static contact angles could provide a
good approximate to the experimental results, while the dynamic contact angles were a little
more complex to use in the flow equations since the contact with two of the microchannel walls
remains unknown.
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Table 5-18 Validation data (Plasma)
Flow rate of the entire flow resistor mean±SD (nL/s)
Resistance of the Flow resistor (m-3)

Pluronic/PDMS [2 µL/g]

Pluronic/PDMS [4 µL/g]

1.02 E+17

9.31

8.72

4.35 E+17

2.35

2.20

8.80 E+17

1.17

1.09

2.35 E+18

0.49

0.46

Comparison of theoretical and experimental flow rate
14
Pluronic functionalized
PDMS [2 µL/g]-calculated
Pluronic functionalized
PDMS [2 µL/g]-measured
Pluronic functionalized
PDMS [4 µL/g]-calculated
Pluronic functionalized
PDMS [4 µL/g]-measured

12

Flow rate (nL/s)

10

8

6

4

2

0
1.02 E+17

4.35 E+17

8.80 E+17

2.35 E+18

Total resistance of flow resistor (m-3)
Figure 5-16 Comparison of the experimentally measured and the theoretically calculated flow
rate using the static contact angles.
Table 5-18 shows the calculated flow rate using the equations in chapter 3, and assuming
the four angles to be equivalent to the measured static contact angle. Results showed that static
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contact angle can serve as good predictor of the flow rate, even though it does not account for the
resistance of the microchannels (Figure 5-16).

5.3 Evaluation of the Integrated LFD with Human Whole Blood
5.3.1 Background

A major requirement for the development of point-of-care tests for the detection of
disease analytes is the need to separate high quality plasma from whole blood efficiently and
rapidly [151]. Methods such as centrifugation require additional equipment to separate the
plasma fraction from the red blood cells [151], so they are not convenient for point of care
applications. The highly asymmetric nature of a plasma separation membrane allows the cellular
components of the blood (red cells, white cells, and platelets) to be captured in the larger pores
without lysis, while the plasma flows down into the smaller pores on the downstream side of the
membrane [152]. Additionally, plasma separation membranes are inexpensive and easy to
integrate in microfluidic platforms.
5.3.2 Method

The blood separation membrane VividTM GR (Pall Corporation) was selected for the
utilization in the LFD because it has the highest plasma yield (~80%) according to the
manufacturer. After the LFD was assembled, the plasma separation membrane was cut of a
slightly smaller size than that of the window opening (18mm by 5mm), and placed on top of the
CP1 (dull size facing up). The contact between the membrane and the CP structures needs to be
very good for a successfully separation (Figure 4-1). The 0.9 cm2 membrane can separate up to
36 µL of plasma from 45 µL of whole blood. 30 µL of whole blood were then deposited on top
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of the membrane and slowly absorbed by it. Red blood cells, white blood cells, and platelets
were trapped on top part of the membrane due to their size being larger than the membrane’s
pores, and only plasma (24 µL) was able to pass through the membrane and then driven through
the channel.

5.4 Microscope Imaging and Data Analysis
5.4.1 Microscope Imaging

A Nikon Eclipse Ti microscope was used to image and evaluate the flow separation
capabilities of the membrane for whole blood separation and the flow speeds for fluidic driven
(such as plasma and PBS). During the imaging, a 40 μL droplet of liquid was placed in the inlet
port of the device, and the fluid was transported by capillarity and a time-lapse recording was
taken in the flow resistor area in order to observe the combined effect of the flow resistance and
the Pluronic concentration. For the analysis of the blood separation efficiency, 30 μL of human
whole blood (Innovative Research) were deposited on the GR plasma separation membrane, and
a time-lapse recording was taken in the CP1 area to image a contact region of the plasma
separation membrane with the CP1 microstructures.
5.4.2 Data Analysis

Flow speed was analyzed at the entrance and middle of the flow resistor to observe its
dynamic change due to the pressure drop between the beginning and end of the rectangular
microchannel [153]. The overall flow rate of the device was calculated by timing the fluid from
entrance to exit of each component, and then dividing the volume of the specific component by
the time the fluid spent going across it. Blood separation efficiency was analyzed using
microscopy techniques to evaluate the quality of the plasma separated. Flow rate and flow speed
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analysis were performed using the time-lapse results by the NIS-Elements Viewer (Nikon
Instruments Inc.). Dynamic contact angle measurements were performed manually using a
protractor. For statistical analysis, data was presented as the mean ± standard deviation (SD) and
each individual experiment was performed at least three times (n ≥3).
5.4.3 Results

High quality separated plasma (no leakage of red or white blood cells) was obtained with
the GR membrane. Figure 5-17 shows the plasma separation process, beginning by pipetting
human whole blood is pipetted on top of the GR membrane.
Table 5-19 compares the average velocity of the fluid at the entrance of the flow resistor
for commercially available plasma (separated using other methods such as centrifugation) and
plasma separated using the Vivid GR separation membrane. The velocity of the separated plasma
was highly consistent with that of the centrifuged plasma.

Figure 5-17 Plasma separation from whole blood. A) Ready to separate. B) Start to separate. C)
Continuous separation. The black arrows indicate the direction of the flow.
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Table 5-19 Comparison of flow rates of the flow resistor (entrance) for separated plasma from
whole blood and just plasma. The substrate used was Pluronic functionalized PDMS
(Pluronic/PDMS [4 µL/g]).
Plasma
Flow resistance
(m-3)
Average Velocity
mean ± SD (µm/s)
Depth of channel
(µm)
Width of channel
(µm)
Flow rate (nL/s)

Separated Plasma from whole blood
8.80 E+17
375±73.54
25
200
1.87

Flow resistance
(m-3)
Average Velocity
mean ± SD (µm/s)
Depth of channel
(µm)
Width of channel
(µm)
Flow rate (nL/s)

8.80 E+17
385±24.09
25
200
1.92

77

Chapter 6 Conclusions and Future Work
In order to bridge the healthcare gap between developing and developed countries, there
is a growing need for integrated, low cost solutions that are easy to handle, and that are able to
provide high quality results. Microfuidics is a powerful alternative for addressing this objective,
however, most of current technologies are not fully integrated in-chip, and therefore require
external equipment which is expensive and not portable.
The LFD developed in this work is able to overcome this problematic, by integrating all
functions in-chip, allowing for the performance of entire laboratory protocols for immunoassays
without the need of any external equipment. The LFD combines the ability to separate plasma
from a small sample of whole blood, initiate and control the fluid flow taking advantage of
capillary forces, and the potential to implement to implement a wide range of immunoassays.
The patient would need only to provide a sample droplet of whole blood, and would be able to
see the results within the course of several minutes. This platform is sensitive, versatile, and easy
to use, which makes it a great alternative for point-of-care testing.
In this work PDMS was functionalized using Pluronic F127, in order to render it
hydrophilic. Because time is a critical factor in performing sandwich immunoassays, flow rate
was controlled by several factors, including the structures size and position in thee capillary
pumps, the concentration of pluronic, and by tuning the resistance of the flow resistor. It was
observed from the experiments that the resistance of the flow resistor had the greatest effect on
the flow rate of the fluids. Plasma flow rates ranging between 0.43 and 18.60 nL/s were achieved
in the flow resistor, and between 0.99 and 61.30 nL/s in the whole device. Even though water
treatment presents an alternative for stabilizing the pluronic and preventing non-specific
absorption, it is key to find ways to control evaporation.
Efforts are currently been made to test the device using different detection techniques
such as colorimetric and fluorescence, for the detection of Immunoglobulin G (IgG), and
traumatic brain injury biomarkers, but the LFD can be used for a diversity of targets.
The current platform is designed for the detection of a single biomarker, but it will be
further modified to obtain multiplexing capabilities, which would allow generating more
meaningful and conclusive information for clinical diagnosis (Figure 6-1).

Figure 6-1 Schematic of potential design for a multiplexing platform.
78

Bibliography
[1] D. H. Peters, A. Garg, G. Bloom, D. G. Walker, W. R. Brieger, and M. H. Rahman, “Poverty
and access to health care in developing countries,” Ann. N. Y. Acad. Sci., vol. 1136, pp. 161–
171, 2008.
[2] C. Gouvea, “Biosensors for health applications,” in Biosensors for Health, Environment and
Biosecurity, P. A. Serra, Ed. InTech, 2011.
[3] L. Gervais, N. de Rooij, and E. Delamarche, “Microfluidic Chips for Point-of-Care
Immunodiagnostics,” Adv. Mater., vol. 23, no. 24, pp. H151–H176, Jun. 2011.
[4] D. Juncker, “CAPILLARY MICROFLUIDIC SYSTEMS FOR BIO/CHEMISTRY,”
Universit_e de Neuchatel, Zurich, 2002.
[5] Fluigent, “What is Microfluidics ?” [Online]. Available: http://www.fluigent.com/what-ismicrofluidics/. [Accessed: 29-Jan-2016].
[6] T. Vestad, D. W. M. Marr, and J. Oakey, “Flow control for capillary-pumped microfluidic
systems,” J. Micromechanics Microengineering, vol. 14, no. 11, pp. 1503–1506, Nov. 2004.
[7] K. Ohno, K. Tachikawa, and A. Manz, “Microfluidics: applications for analytical purposes in
chemistry and biochemistry,” Electrophoresis, vol. 29, no. 22, pp. 4443–4453, Nov. 2008.
[8] N. S. Lynn and D. S. Dandy, “Passive microfluidic pumping using coupled
capillary/evaporation effects,” Lab. Chip, vol. 9, no. 23, p. 3422, 2009.
[9] D. Juncker, H. Schmid, U. Drechsler, H. Wolf, M. Wolf, B. Michel, N. de Rooij, and E.
Delamarche, “Autonomous Microfluidic Capillary System,” Anal. Chem., vol. 74, no. 24, pp.
6139–6144, Dec. 2002.
[10] H. Zhu, M. Bilgin, R. Bangham, D. Hall, A. Casamayor, P. Bertone, N. Lan, R. Jansen, S.
Bidlingmaier, T. Houfek, T. Mitchell, P. Miller, R. A. Dean, M. Gerstein, and M. Snyder,
“Global analysis of protein activities using proteome chips,” Science, vol. 293, no. 5537, pp.
2101–2105, Sep. 2001.
[11] M. A. Burns, “An Integrated Nanoliter DNA Analysis Device,” Science, vol. 282, no.
5388, pp. 484–487, Oct. 1998.
[12] [Mu] TAS 2001 Symposium, A. van den Berg, and J. M. Ramsey, Micro total analysis
systems 2001 proceedings of the [mu]TAS 2001 Symposium, held in Monterey, CA, USA, 2125 October, 2001. Dordrecht: Springer, 2001.
[13] M. Ahmadi, J. Yeow, and M. Shahini, “System Integration in Microfluidics,” in
Microfluidics and Nanofluidics Handbook, CRC Press, 2011, pp. 269–286.
[14] T. Matsunaga, M. Hosokawa, A. Arakaki, T. Taguchi, T. Mori, T. Tanaka, and H.
Takeyama, “High-efficiency single-cell entrapment and fluorescence in situ hybridization
analysis using a poly(dimethylsiloxane) microfluidic device integrated with a black
poly(ethylene terephthalate) micromesh,” Anal. Chem., vol. 80, no. 13, pp. 5139–5145, Jul.
2008.
[15] J. Zhou, D. A. Khodakov, A. V. Ellis, and N. H. Voelcker, “Surface modification for
PDMS-based microfluidic devices,” ELECTROPHORESIS, vol. 33, no. 1, pp. 89–104, Jan.
2012.
[16] G. M. Whitesides, “The origins and the future of microfluidics,” Nature, vol. 442, no.
7101, pp. 368–373, Jul. 2006.
[17] V. Gubala, L. F. Harris, A. J. Ricco, M. X. Tan, and D. E. Williams, “Point of Care
Diagnostics: Status and Future,” Anal. Chem., vol. 84, no. 2, pp. 487–515, Jan. 2012.
79

[18] L. J. Thomas and S. P. Bessman, “Prototype for an implantable micropump powdered by
piezoelectric disk benders,” Trans. - Am. Soc. Artif. Intern. Organs, vol. 21, pp. 516–522,
1975.
[19] W. J. Spencer, W. T. Corbett, L. R. Dominguez, and B. D. Shafer, “An electronically
controlled piezoelectric insulin pump and valves,” IEEE Trans. Sonics Ultrason., vol. 25, no.
3, pp. 153–156, May 1978.
[20] P. Woias, “Micropumps—past, progress and future prospects,” Sens. Actuators B Chem.,
vol. 105, no. 1, pp. 28–38, Feb. 2005.
[21] A. Manz, N. Graber, and H. M. Widmer, “Miniaturized total chemical analysis systems:
A novel concept for chemical sensing,” Sens. Actuators B Chem., vol. 1, no. 1–6, pp. 244–
248, Jan. 1990.
[22] D. J. Harrison, A. Manz, Z. Fan, H. Luedi, and H. M. Widmer, “Capillary electrophoresis
and sample injection systems integrated on a planar glass chip,” Anal. Chem., vol. 64, no. 17,
pp. 1926–1932, Sep. 1992.
[23] D. J. Harrison, K. Fluri, K. Seiler, Z. Fan, C. S. Effenhauser, and A. Manz,
“Micromachining a Miniaturized Capillary Electrophoresis-Based Chemical Analysis
System on a Chip,” Science, vol. 261, no. 5123, pp. 895–897, Aug. 1993.
[24] D. Issadore and R. M. Westervelt, Eds., Point-of-Care Diagnostics on a Chip. Berlin,
Heidelberg: Springer Berlin Heidelberg, 2013.
[25] L. Gervais, “Capillary Microfluidic Chips for Point-of-Care Testing: from Research
Tools to Decentralized Medical Diagnostics,” ÉCOLE POLYTECHNIQUE FÉDÉRALE DE
LAUSANNE, Suisse, 2011.
[26] S. K. Sia and L. J. Kricka, “Microfluidics and point-of-care testing,” Lab. Chip, vol. 8, no.
12, p. 1982, 2008.
[27] U. Demirci, Ed., Microfluidic technologies for human health. New Jersey : London:
World Scientific Pub. ; Imperial College Press, 2013.
[28] D. A. Hall, J. Ptacek, and M. Snyder, “Protein microarray technology,” Mech. Ageing
Dev., vol. 128, no. 1, pp. 161–167, Jan. 2007.
[29] M.-I. Mohammed and M. P. Y. Desmulliez, “Lab-on-a-chip based immunosensor
principles and technologies for the detection of cardiac biomarkers: a review,” Lab Chip, vol.
11, no. 4, pp. 569–595, 2011.
[30] L. Wu, C. Ma, L. Ge, Q. Kong, M. Yan, S. Ge, and J. Yu, “Paper-based
electrochemiluminescence origami cyto-device for multiple cancer cells detection using
porous AuPd alloy as catalytically promoted nanolabels,” Biosens. Bioelectron., vol. 63, pp.
450–457, Jan. 2015.
[31] Y. Wu, P. Xue, K. M. Hui, and Y. Kang, “A paper-based microfluidic electrochemical
immunodevice integrated with amplification-by-polymerization for the ultrasensitive
multiplexed detection of cancer biomarkers,” Biosens. Bioelectron., vol. 52, pp. 180–187,
Feb. 2014.
[32] S. Wang, L. Ge, X. Song, J. Yu, S. Ge, J. Huang, and F. Zeng, “Paper-based
chemiluminescence ELISA: lab-on-paper based on chitosan modified paper device and waxscreen-printing,” Biosens. Bioelectron., vol. 31, no. 1, pp. 212–218, Jan. 2012.
[33] P. Wang, L. Ge, M. Yan, X. Song, S. Ge, and J. Yu, “Paper-based three-dimensional
electrochemical immunodevice based on multi-walled carbon nanotubes functionalized paper
for sensitive point-of-care testing,” Biosens. Bioelectron., vol. 32, no. 1, pp. 238–243, Feb.
2012.
80

[34] W. Li, M. Li, S. Ge, M. Yan, J. Huang, and J. Yu, “Battery-triggered ultrasensitive
electrochemiluminescence detection on microfluidic paper-based immunodevice based on
dual-signal amplification strategy,” Anal. Chim. Acta, vol. 767, pp. 66–74, Mar. 2013.
[35] S. Wang, L. Ge, M. Yan, J. Yu, X. Song, S. Ge, and J. Huang, “3D microfluidic origami
electrochemiluminescence immunodevice for sensitive point-of-care testing of carcinoma
antigen 125,” Sens. Actuators B Chem., vol. 176, pp. 1–8, Jan. 2013.
[36] N. P. Sardesai, K. Kadimisetty, R. Faria, and J. F. Rusling, “A microfluidic
electrochemiluminescent device for detecting cancer biomarker proteins,” Anal. Bioanal.
Chem., vol. 405, no. 11, pp. 3831–3838, Apr. 2013.
[37] X. Zhou, T. I. Wong, H. Y. Song, L. Wu, Y. Wang, P. Bai, D.-H. Kim, S. H. Ng, M. S.
Tse, and W. Knoll, “Development of Localized Surface Plasmon Resonance-Based Point-ofCare System,” Plasmonics, vol. 9, no. 4, pp. 835–844, Aug. 2014.
[38] S. T. Sanjay, G. Fu, M. Dou, F. Xu, R. Liu, H. Qi, and X. Li, “Biomarker detection for
disease diagnosis using cost-effective microfluidic platforms,” The Analyst, vol. 140, no. 21,
pp. 7062–7081, 2015.
[39] S. T. Sanjay, G. Fu, M. Dou, F. Xu, R. Liu, H. Qi, and X. Li, “Biomarker detection for
disease diagnosis using cost-effective microfluidic platforms,” The Analyst, vol. 140, no. 21,
pp. 7062–7081, 2015.
[40] K.-W. Chang, J. Li, C.-H. Yang, S.-C. Shiesh, and G.-B. Lee, “An integrated
microfluidic system for measurement of glycated hemoglobin levels by using an aptamerantibody assay on magnetic beads,” Biosens. Bioelectron., vol. 68, pp. 397–403, Jun. 2015.
[41] K.-W. Chang, J.-L. Li, C.-H. Yang, S.-C. Shiesh, and G.-B. Lee, “Measurement of
glycated hemoglobin using an aptamer/antibody assay on an integrated microfluidic system,”
2014, pp. 647–650.
[42] C.-C. Wu, H.-I. Lin, K.-W. Chang, J. D. Mai, S.-C. Shiesh, and G.-B. Lee, “Measurement
of glycated hemoglobin levels using an integrated microfluidic system,” Microfluid.
Nanofluidics, vol. 18, no. 4, pp. 613–621, Apr. 2015.
[43] J.-W. Choi, K. W. Oh, J. H. Thomas, W. R. Heineman, H. B. Halsall, J. H. Nevin, A. J.
Helmicki, H. T. Henderson, and C. H. Ahn, “An integrated microfluidic biochemical
detection system for protein analysis with magnetic bead-based sampling capabilities,” Lab.
Chip, vol. 2, no. 1, p. 27, 2002.
[44] S. Wang, L. Ge, X. Song, J. Yu, S. Ge, J. Huang, and F. Zeng, “Paper-based
chemiluminescence ELISA: lab-on-paper based on chitosan modified paper device and waxscreen-printing,” Biosens. Bioelectron., vol. 31, no. 1, pp. 212–218, Jan. 2012.
[45] E. Anderson, M. Conway, H. Alloush, K. O’Malley, M. A. Smith, A. Martin, M.
Ruddock, C. Reid, J. Lamont, S. P. Fitzgerald, J. G. Smith, P. Mehta, and V. Salisbury,
“Investigation and verification of a bioluminescent biosensor for the quantitation of ara-CTP
generation: a biomarker for cytosine arabinoside sensitivity in acute myeloid leukaemia,”
Biosens. Bioelectron., vol. 52, pp. 345–353, Feb. 2014.
[46] N. V. Zaytseva, R. A. Montagna, and A. J. Baeumner, “Microfluidic Biosensor for the
Serotype-Specific Detection of Dengue Virus RNA,” Anal. Chem., vol. 77, no. 23, pp. 7520–
7527, Dec. 2005.
[47] A. J. Baeumner, N. A. Schlesinger, N. S. Slutzki, J. Romano, E. M. Lee, and R. A.
Montagna, “Biosensor for Dengue Virus Detection: Sensitive, Rapid, and Serotype Specific,”
Anal. Chem., vol. 74, no. 6, pp. 1442–1448, Mar. 2002.

81

[48] Y.-F. Lee, K.-Y. Lien, H.-Y. Lei, and G.-B. Lee, “An integrated microfluidic system for
rapid diagnosis of dengue virus infection,” Biosens. Bioelectron., vol. 25, no. 4, pp. 745–752,
Dec. 2009.
[49] M. Dou, D. C. Dominguez, X. Li, J. Sanchez, and G. Scott, “A versatile PDMS/paper
hybrid microfluidic platform for sensitive infectious disease diagnosis,” Anal. Chem., vol. 86,
no. 15, pp. 7978–7986, Aug. 2014.
[50] J. Pipper, M. Inoue, L. F.-P. Ng, P. Neuzil, Y. Zhang, and L. Novak, “Catching bird flu in
a droplet,” Nat. Med., vol. 13, no. 10, pp. 1259–1263, Nov. 2007.
[51] M. Hu, J. Yan, Y. He, H. Lu, L. Weng, S. Song, C. Fan, and L. Wang, “Ultrasensitive,
Multiplexed Detection of Cancer Biomarkers Directly in Serum by Using a Quantum DotBased Microfluidic Protein Chip,” ACS Nano, vol. 4, no. 1, pp. 488–494, Jan. 2010.
[52] Y.-F. Lee, K.-Y. Lien, H.-Y. Lei, and G.-B. Lee, “An integrated microfluidic system for
rapid diagnosis of dengue virus infection,” Biosens. Bioelectron., vol. 25, no. 4, pp. 745–752,
Dec. 2009.
[53] D. Maji, M. A. Suster, E. Stavrou, U. A. Gurkan, and P. Mohseni, “Monitoring time
course of human whole blood coagulation using a microfluidic dielectric sensor with a 3D
capacitive structure,” Conf. Proc. Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. IEEE Eng.
Med. Biol. Soc. Annu. Conf., vol. 2015, pp. 5904–5907, Aug. 2015.
[54] K. Länge, B. E. Rapp, and M. Rapp, “Surface acoustic wave biosensors: a review,” Anal.
Bioanal. Chem., vol. 391, no. 5, pp. 1509–1519, Jul. 2008.
[55] X. Zhang, Y. Zou, C. An, K. Ying, X. Chen, and P. Wang, “A miniaturized
immunosensor platform for automatic detection of carcinoembryonic antigen in EBC,” Sens.
Actuators B Chem., vol. 205, pp. 94–101, Dec. 2014.
[56] T. M. A. Gronewold, “Surface acoustic wave sensors in the bioanalytical field: Recent
trends and challenges,” Anal. Chim. Acta, vol. 603, no. 2, pp. 119–128, Nov. 2007.
[57] D. Vilela, M. C. González, and A. Escarpa, “Sensing colorimetric approaches based on
gold and silver nanoparticles aggregation: chemical creativity behind the assay. A review,”
Anal. Chim. Acta, vol. 751, pp. 24–43, Nov. 2012.
[58] W. Qu, Y. Liu, D. Liu, Z. Wang, and X. Jiang, “Copper-Mediated Amplification Allows
Readout of Immunoassays by the Naked Eye,” Angew. Chem., vol. 123, no. 15, pp. 3504–
3507, Apr. 2011.
[59] “How Pregnancy Tests Work.” [Online]. Available:
http://chemistry.about.com/od/chemistryfaqs/f/pregnancytest.htm. [Accessed: 14-Jul-2014].
[60] “Pregnancy Test Strip Instructions.” [Online]. Available: http://www.early-pregnancytests.com/inpregtesstr.html. [Accessed: 14-Jul-2014].
[61] L. Yu, C. M. Li, Y. Liu, J. Gao, W. Wang, and Y. Gan, “Flow-through functionalized
PDMS microfluidic channels with dextran derivative for ELISAs,” Lab. Chip, vol. 9, no. 9, p.
1243, 2009.
[62] C. D. Chin, T. Laksanasopin, Y. K. Cheung, D. Steinmiller, V. Linder, H. Parsa, J. Wang,
H. Moore, R. Rouse, G. Umviligihozo, E. Karita, L. Mwambarangwe, S. L. Braunstein, J.
van de Wijgert, R. Sahabo, J. E. Justman, W. El-Sadr, and S. K. Sia, “Microfluidics-based
diagnostics of infectious diseases in the developing world,” Nat. Med., vol. 17, no. 8, pp.
1015–1019, Jul. 2011.
[63] W. Du, L. Li, K. P. Nichols, and R. F. Ismagilov, “SlipChip,” Lab. Chip, vol. 9, no. 16, p.
2286, 2009.

82

[64] “3D Printed Diagnostic Device Rapidly Detects Anemia.” [Online]. Available:
http://www.mdtmag.com/news/2016/02/3d-printed-diagnostic-device-rapidly-detects-anemia.
[Accessed: 03-Mar-2016].
[65] E. Petryayeva and U. J. Krull, “Localized surface plasmon resonance: Nanostructures,
bioassays and biosensing—A review,” Anal. Chim. Acta, vol. 706, no. 1, pp. 8–24, Nov.
2011.
[66] T. Lai, Q. Hou, H. Yang, X. Luo, and M. Xi, “Clinical application of a novel sliver
nanoparticles biosensor based on localized surface plasmon resonance for detecting the
microalbuminuria,” Acta Biochim. Biophys. Sin., vol. 42, no. 11, pp. 787–792, Nov. 2010.
[67] P. Liu, X. Li, S. A. Greenspoon, J. R. Scherer, and R. A. Mathies, “Integrated DNA
purification, PCR, sample cleanup, and capillary electrophoresis microchip for forensic
human identification,” Lab. Chip, vol. 11, no. 6, pp. 1041–1048, Mar. 2011.
[68] B. S. Lee, Y. U. Lee, H.-S. Kim, T.-H. Kim, J. Park, J.-G. Lee, J. Kim, H. Kim, W. G.
Lee, and Y.-K. Cho, “Fully integrated lab-on-a-disc for simultaneous analysis of
biochemistry and immunoassay from whole blood,” Lab Chip, vol. 11, no. 1, pp. 70–78,
2011.
[69] J. Nguyen, Y. Wei, Y. Zheng, C. Wang, and Y. Sun, “On-chip sample preparation for
complete blood count from raw blood,” Lab. Chip, vol. 15, no. 6, pp. 1533–1544, Mar. 2015.
[70] X. Mao and T. J. Huang, “Microfluidic diagnostics for the developing world,” Lab. Chip,
vol. 12, no. 8, p. 1412, 2012.
[71] E A BOUCHER, “Capillary phenomena: Properties of systems with fluid/fluid interfaces,”
University of Sussex, UK, 1980.
[72] Aleksandr Mikhaïlovich Prokhorov, “Capillary Phenomena,” Great Soviet Encyclopedia.
1979.
[73] Nelli, Giovan Battista, “Saggio di storia letteraria fiorentina del secolo XVII,” 1759.
[74] R. Boyle, New experiments physico-mechanicall, touching the spring of the air, and its
effects. 1660.
[75] J. C. Sturm, Collegium Experimentale sive Curiosum, vol. 1. University of Lausanne,
1676.
[76] G. Sinclair, Ars nova et magna gravitatis et levitatis. .
[77] Montanari, Geminiano, “Pensieri fisico-matematici sopra alcune esperienze fatte in
Bologna nell’Accademia Filosofica... intorno diversi effetti de’ liquidi in cannuccie di vetro
et altri vasi,” 1667.
[78] R. Hooke, Octavo Corporation, and Warnock Library, Micrographia. Palo Alto, Ca.:
Octavo, 1998.
[79] R. Hooke, An attempt for the explication of the phænomena observable in an experiment
published by the Honourable Robert Boyle, Esq., in the XXXV experiment of his epistolical
discourse touching the aire in confirmation of a former conjecture made by R.H. Ann Arbor,
MI ; Oxford (UK).
[80] J. Bernoulli, Jacobi Bernoulli Dissertatio de gravitate ætheris. Apud H. Wetstenium,
1683.
[81] Honoré Fabri, Dialogi physici, in quibus de motu Terrae disputatur, marini aestus nova
causa proponitur. Sumptibus Christophori Fourmy, in vico Mercatorio, sub signo Occasionis,
1665.
[82] I. Vossius, De Nili et aliorum fluminum origine. Universiteit Gent: Ex typographia
Adriani Vlacq, 1666.
83

[83] L. Carré, Experiences sur les tuyaux Capillaires. 1705.
[84] G. A. Borelli, De Motionibus Naturalibus, A Gravitate Pendentibus. Lugduni
Batavorum//Leiden: Apud Petrum Vander Aa, 1686.
[85] F. Hauksbee, “Several Experiments Touching the Seeming Spontaneous Ascent of Water.
By Mr. Fr. Hauksbee, F. R. S.,” Philos. Trans. R. Soc. Lond., vol. 26, no. 313–324, pp. 258–
266, Jan. 1708.
[86] Hauksbee, Francis, “Physico-mechanical experiments on various subjects containing an
account of several surprizing phenomena touching light and electricity, producible on the
attrition of bodies : with many other remarkable appearances, not before observ’d : together
with the explanations of all the machines, (the figures of which are curiously engrav’d on
copper) and other apparatus us’d in making the experiments,” 1709.
[87] F. Hauksbee, “An Account of an Experiment Touching the Direction of a Drop of Oil of
Oranges, between Two Glass Planes, towards Any Side of Them That is Nearest Press’d
Together. By Mr. Fr. Hauksbee, F. R. S.,” Philos. Trans. R. Soc. Lond., vol. 27, no. 325–336,
pp. 395–396, Jan. 1710.
[88] J. Weitbrecht, Tentamen theoriae qua ascensus aquae in tubis capillaribus explicatur, vol.
8. 1736.
[89] J. Weitbrecht, Explicatio difficilium experimentorum circa ascensum aquae in tubis
capillaribus, vol. 9. 1737.
[90] T. Young, “An Essay on the Cohesion of Fluids,” Philos. Trans. R. Soc. Lond., vol. 95,
no. 0, pp. 65–87, Jan. 1805.
[91] Pierre Simon marquis de Laplace, Traité de Mécanique Céleste, vol. 4. Paris, 1805.
[92] C. F. Gauss, Principia generalia Theoriae Figurae Fluidorum in statu Aequilibrii.
Germany, 1830.
[93] F. Neumann and A. Wangerin, Vorlesungen über die Theorie der Capillarität. Germany,
1894.
[94] W. Thomson, “On the equilibrium of vapour at a curved surface of liquid,” Philosophical
Magazine, pp. 448–452, 1871.
[95] J. N. Israelachvili, Intermolecular and surface forces, 3rd ed. Burlington, MA: Academic
Press, 2011.
[96] P. G. de Gennes, “Wetting: statics and dynamics,” Rev. Mod. Phys., vol. 57, no. 3, pp.
827–863, Jul. 1985.
[97] M. Nosonovsky and R. Ramachandran, “Geometric Interpretation of Surface Tension
Equilibrium in Superhydrophobic Systems,” Entropy, vol. 17, no. 7, pp. 4684–4700, Jul.
2015.
[98] M. Zimmermann, H. Schmid, P. Hunziker, and E. Delamarche, “Capillary pumps for
autonomous capillary systems,” Lab. Chip, vol. 7, no. 1, p. 119, 2007.
[99] G. A. Urban, Ed., BioMEMS. Dordrecht: Springer, 2006.
[100] J. P. Brody, P. Yager, R. E. Goldstein, and R. H. Austin, “Biotechnology at low Reynolds
numbers,” Biophys. J., vol. 71, no. 6, pp. 3430–3441, Dec. 1996.
[101] T. M. Squires and S. R. Quake, “Microfluidics: Fluid physics at the nanoliter scale,” Rev.
Mod. Phys., vol. 77, no. 3, pp. 977–1026, Oct. 2005.
[102] A. Biral, “Microfluidic networking: modelling and analysis,” UNIVERSITA DEGLI
STUDI DI PADOVA, 2012.
[103] “Viscosity - The Physics Hypertextbook.” [Online]. Available:
http://physics.info/viscosity/. [Accessed: 14-Feb-2016].
84

[104] “Viscosity - Wikipedia, the free encyclopedia.” [Online]. Available:
https://en.wikipedia.org/wiki/Viscosity. [Accessed: 14-Feb-2016].
[105] Meridian Valley Lab, “Whole Blood Viscosity vs. Serum and Plasma Viscosity.”
[Online]. Available: http://meridianvalleylab.com/whole-blood-viscosity-vs-serum-andplasma-viscosity. [Accessed: 03-Feb-2015].
[106] G. Késmárky, P. Kenyeres, M. Rábai, and K. Tóth, “Plasma viscosity: a forgotten
variable,” Clin. Hemorheol. Microcirc., vol. 39, no. 1–4, pp. 243–246, 2008.
[107] “biofilm_doseresponse_pg1 - 168_BioFlux_Viscosity_TechNote-1038-01.pdf.” .
[108] “POISEUILLE’S LAW AND THE VISCOSITY OF FLUIDS.” [Online]. Available:
http://galileo.phys.virginia.edu/classes/241L/poise/poise.htm. [Accessed: 15-Feb-2016].
[109] F. Rodriguez, “The analogy between fluid flow and electric circuitry,” Ithaca, New York.
[110] Hutchinson (Firm), The Hutchinson unabridged encyclopedia with atlas and weather
guide. Oxford, England: Helicon, 2010.
[111] D. J. Beebe, G. A. Mensing, and G. M. Walker, “Physics and Applications of
Microfluidics in Biology,” Annu. Rev. Biomed. Eng., vol. 4, no. 1, pp. 261–286, Aug. 2002.
[112] H. van Heeren and P. Hewkin, “Design for Microfluidic Device Manufacture Guidelines.”
05-Apr-2014.
[113] G. M. Whitesides, “The origins and the future of microfluidics,” Nature, vol. 442, no.
7101, pp. 368–373, Jul. 2006.
[114] J. P. Brody, P. Yager, R. E. Goldstein, and R. H. Austin, “Biotechnology at low Reynolds
numbers,” Biophys. J., vol. 71, no. 6, pp. 3430–3441, Dec. 1996.
[115] L. A. Godwin, K. S. Deal, L. D. Hoepfner, L. A. Jackson, and C. J. Easley,
“Measurement of microchannel fluidic resistance with a standard voltage meter,” Anal. Chim.
Acta, vol. 758, pp. 101–107, Jan. 2013.
[116] P. Abgrall and A.-M. Gué, “Lab-on-chip technologies: making a microfluidic network
and coupling it into a complete microsystem—a review,” J. Micromechanics
Microengineering, vol. 17, no. 5, pp. R15–R49, May 2007.
[117] K. Ren, J. Zhou, and H. Wu, “Materials for Microfluidic Chip Fabrication,” Acc. Chem.
Res., vol. 46, no. 11, pp. 2396–2406, Nov. 2013.
[118] “Microfluidics? A general overview.” [Online]. Available:
http://www.elveflow.com/microfluidic-tutorials/microfluidic-reviews-andtutorials/microfluidics/. [Accessed: 26-Mar-2016].
[119] K. F. Lei, “Chapter 1. Materials and Fabrication Techniques for Nano- and Microfluidic
Devices,” in RSC Detection Science, F. H. Labeed and H. O. Fatoyinbo, Eds. Cambridge:
Royal Society of Chemistry, 2014, pp. 1–28.
[120] A. W. Martinez, S. T. Phillips, G. M. Whitesides, and E. Carrilho, “Diagnostics for the
Developing World: Microfluidic Paper-Based Analytical Devices,” Anal. Chem., vol. 82, no.
1, pp. 3–10, Jan. 2010.
[121] R. G. Blazej, P. Kumaresan, and R. A. Mathies, “Microfabricated bioprocessor for
integrated nanoliter-scale Sanger DNA sequencing,” Proc. Natl. Acad. Sci., vol. 103, no. 19,
pp. 7240–7245, May 2006.
[122] T. G. Henares, F. Mizutani, and H. Hisamoto, “Current development in microfluidic
immunosensing chip,” Anal. Chim. Acta, vol. 611, no. 1, pp. 17–30, Mar. 2008.
[123] K. Kalkandjiev, L. Riegger, D. Kosse, M. Welsche, L. Gutzweiler, R. Zengerle, and P.
Koltay, “Microfluidics in silicon/polymer technology as a cost-efficient alternative to
silicon/glass,” J. Micromechanics Microengineering, vol. 21, no. 2, p. 25008, Feb. 2011.
85

[124] M. Grundner and H. Jacob, “Investigations on hydrophilic and hydrophobic silicon (100)
wafer surfaces by X-ray photoelectron and high-resolution electron energy lossspectroscopy,” Appl. Phys. Solids Surf., vol. 39, no. 2, pp. 73–82, Feb. 1986.
[125] W. Kern and D.A. Puotinen, “Cleaning Solutions Based on Hydrogen Peroxide for Use in
Silicon Semiconductor Technology,” vol. 31, pp. 187–206, 1970.
[126] B. R. Benson, H. A. Stone, and R. K. Prud’homme, “An ‘off-the-shelf’ capillary
microfluidic device that enables tuning of the droplet breakup regime at constant flow rates,”
Lab. Chip, vol. 13, no. 23, p. 4507, 2013.
[127] Z. Chang, C. A. Serra, M. Bouquey, L. Prat, and G. Hadziioannou, “Co-axial capillaries
microfluidic device for synthesizing size- and morphology-controlled polymer core-polymer
shell particles,” Lab. Chip, vol. 9, no. 20, pp. 3007–3011, Oct. 2009.
[128] W. Wang, R. Xie, X.-J. Ju, T. Luo, L. Liu, D. A. Weitz, and L.-Y. Chu, “Controllable
microfluidic production of multicomponent multiple emulsions,” Lab. Chip, vol. 11, no. 9,
pp. 1587–1592, May 2011.
[129] X. Li, D. R. Ballerini, and W. Shen, “A perspective on paper-based microfluidics:
Current status and future trends,” Biomicrofluidics, vol. 6, no. 1, p. 11301, 2012.
[130] R. H. Müller and D. L. Clegg, “Automatic Paper Chromatography,” Anal. Chem., vol. 21,
no. 9, pp. 1123–1125, Sep. 1949.
[131] J. C. McDonald, D. C. Duffy, J. R. Anderson, D. T. Chiu, H. Wu, O. J. Schueller, and G.
M. Whitesides, “Fabrication of microfluidic systems in poly(dimethylsiloxane),”
Electrophoresis, vol. 21, no. 1, pp. 27–40, Jan. 2000.
[132] Y. Zhu and K. Petkovic-Duran, “&lt;title&gt;Capillary flow in polymer microfluidic
chips&lt;/title&gt;,” 2006, p. 64160K–64160K–6.
[133] E. K. Sackmann, A. L. Fulton, and D. J. Beebe, “The present and future role of
microfluidics in biomedical research,” Nature, vol. 507, no. 7491, pp. 181–189, Mar. 2014.
[134] K. J. Regehr, M. Domenech, J. T. Koepsel, K. C. Carver, S. J. Ellison-Zelski, W. L.
Murphy, L. A. Schuler, E. T. Alarid, and D. J. Beebe, “Biological implications of
polydimethylsiloxane-based microfluidic cell culture,” Lab. Chip, vol. 9, no. 15, pp. 2132–
2139, Aug. 2009.
[135] M. W. Toepke and D. J. Beebe, “PDMS absorption of small molecules and consequences
in microfluidic applications,” Lab. Chip, vol. 6, no. 12, pp. 1484–1486, Dec. 2006.
[136] E. Berthier, J. Warrick, H. Yu, and D. J. Beebe, “Managing evaporation for more robust
microscale assays. Part 2. Characterization of convection and diffusion for cell biology,” Lab.
Chip, vol. 8, no. 6, pp. 860–864, Jun. 2008.
[137] J. Zhou, A. V. Ellis, and N. H. Voelcker, “Recent developments in PDMS surface
modification for microfluidic devices,” ELECTROPHORESIS, vol. 31, no. 1, pp. 2–16, Jan.
2010.
[138] W. Qiu, X. Sun, C. Wu, K. Hjort, and Z. Wu, “A Contact Angle Study of the Interaction
between Embedded Amphiphilic Molecules and the PDMS Matrix in an Aqueous
Environment,” Micromachines, vol. 5, no. 3, pp. 515–527, Aug. 2014.
[139] Z. Wu and K. Hjort, “Surface modification of PDMS by gradient-induced migration of
embedded Pluronic,” Lab. Chip, vol. 9, no. 11, p. 1500, 2009.
[140]
interfaces: thermodynamics, structure, dynamics, and modeling,” Colloids Surf.
Physicochem. Eng. Asp., vol. 96, no. 1–2, pp. 1–46, Mar. 1995.
86

[141] D. C. Duffy, J. C. McDonald, O. J. A. Schueller, and G. M. Whitesides, “Rapid
Prototyping of Microfluidic Systems in Poly(dimethylsiloxane),” Anal. Chem., vol. 70, no.
23, pp. 4974–4984, Dec. 1998.
[142] D. J. Laser and J. G. Santiago, “A review of micropumps,” J. Micromechanics
Microengineering, vol. 14, no. 6, pp. R35–R64, Jun. 2004.
[143] A. Homsy, “Design, Microfabrication, and Characterization of MHD Pumps and their
Applications in NMR Environments,” University of Neuchâtel, Switzerland, 2006.
[144] M. Gad-el-Hak, Flow control: passive, active, and reactive flow management, 1. publ.,
Digitally printed first paperback version. Cambridge: Cambridge Univ. Press, 2006.
[145] E. Berthier and D. J. Beebe, “Flow rate analysis of a surface tension driven passive
micropump,” Lab. Chip, vol. 7, no. 11, pp. 1475–1478, Nov. 2007.
[146] Y. Zhu and K. Petkovic-Duran, “Capillary flow in microchannels,” Microfluid.
Nanofluidics, vol. 8, no. 2, pp. 275–282, Feb. 2010.
[147] W. Qiu, X. Sun, C. Wu, K. Hjort, and Z. Wu, “A Contact Angle Study of the Interaction
between Embedded Amphiphilic Molecules and the PDMS Matrix in an Aqueous
Environment,” Micromachines, vol. 5, no. 3, pp. 515–527, Aug. 2014.
[148] A. A. Saha, S. K. Mitra, M. Tweedie, S. Roy, and J. McLaughlin, “Experimental and
numerical investigation of capillary flow in SU8 and PDMS microchannels with integrated
pillars,” Microfluid. Nanofluidics, vol. 7, no. 4, pp. 451–465, Oct. 2009.
[149] M. Zimmermann, H. Schmid, P. Hunziker, and E. Delamarche, “Capillary pumps for
autonomous capillary systems,” Lab Chip, vol. 7, no. 1, pp. 119–125, 2007.
[150] D. Myers, Surfaces, Interfaces, and Colloids. New York, USA: John Wiley & Sons, Inc.,
1999.
[151] A. Nabatiyan, Z. A. Parpia, R. Elghanian, and D. M. Kelso, “Membrane-based plasma
collection device for point-of-care diagnosis of HIV,” J. Virol. Methods, vol. 173, no. 1, pp.
37–42, Apr. 2011.
[152] “VividTM Plasma Separation Membrane.” [Online]. Available:
http://www.pall.com/main/oem-materials-and-devices/product.page?id=46962. [Accessed:
12-Jun-2015].
[153] M. Gad-el-Hak, The MEMS handbook. Boca Raton, FL: CRC Press, 2002.
[154] A. van den Berg and L. Segerink, Eds., Microfluidics for medical applications.
Cambridge, UK: Royal Society of Chemistry, 2015.
[155] A. W. Martinez, S. T. Phillips, M. J. Butte, and G. M. Whitesides, “Patterned Paper as a
Platform for Inexpensive, Low-Volume, Portable Bioassays,” Angew. Chem. Int. Ed., vol. 46,
no. 8, pp. 1318–1320, Feb. 2007.
[156] A. W. Martinez, S. T. Phillips, and G. M. Whitesides, “Three-dimensional microfluidic
devices fabricated in layered paper and tape,” Proc. Natl. Acad. Sci., vol. 105, no. 50, pp.
19606–19611, Dec. 2008.
[157] N. K. Thom, K. Yeung, M. B. Pillion, and S. T. Phillips, “‘Fluidic batteries’ as low-cost
sources of power in paper-based microfluidic devices,” Lab. Chip, vol. 12, no. 10, p. 1768,
2012.
[158] N. R. Pollock, J. P. Rolland, S. Kumar, P. D. Beattie, S. Jain, F. Noubary, V. L. Wong, R.
A. Pohlmann, U. S. Ryan, and G. M. Whitesides, “A Paper-Based Multiplexed Transaminase
Test for Low-Cost, Point-of-Care Liver Function Testing,” Sci. Transl. Med., vol. 4, no. 152,
pp. 152ra129–152ra129, Sep. 2012.

87

